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Abstract
Stimuli-responsive hydrogels have attracted significant research interest as they exhibit
triggerable drug release or changes in mechanical properties. Hydrogels containing
dendrimers have also been targeted as their multiple functional groups provide enhanced
crosslinking or chemical conjugation. Self-immolative dendrimers (SIDs) fragment in
response to a stimulus event, but they have not been explored for the preparation of stimuliresponsive hydrogels. This thesis reports the preparation of hydrogels from a 4-arm
poly(ethylene glycol) polymer and SIDs composed of a photosensitive o-nitrobenzyl
carbonate core. The gel content and equilibrium water content were examined as a function
of the hydrogel formulation. Hydrogel degradation was demonstrated using 1H NMR
spectroscopy and measurements of the mechanical properties before and after degradation.
The loading and release of the drug celecoxib from the hydrogels was also investigated.
This work introduces a new implantable stimuli-responsive dendritic hydrogel platform
that can potentially be used for the delivery of celecoxib or cell encapsulation and release.

Keywords
Hydrogels, self-immolative dendrimers, poly(ethylene glycol), photosensitive, drug
delivery.
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Summary for Lay Audience
Certain molecules with tree-like morphologies have attracted a lot of interest due to their
structural precision and functional diversity. Such characteristics afford them various
applications in drug delivery, catalysis, sensors, and agriculture. This group of molecules
has recently been extended to include a new class of materials, which are comprised of
three components: (i) central core (ii) interior branches and (iii) peripheral functional
groups from which molecules are released. The novel species fragment in a domino-like
fashion in response to a trigger event, such as UV light irradiation, at the core. However,
their incorporation into hydrogels has not yet been explored. Hydrogels are of significant
interest for biomedical applications due to their high water content, which resembles that
of tissues. They have been investigated for both cell and drug delivery. This thesis
describes the synthesis of hydrogels that contain photosensitive tree-shaped moieties. Upon
exposure to UV light, the fragmentation of the networks was assessed. The scaffolds were
made to ensure the degradation products were not toxic to the human body. Also, the
durability of the scaffolds in the presence and absence of UV light was examined. Finally,
the hydrogels were loaded with drug molecules to investigate the networks’ drug release
behaviour with and without irradiation. Overall, the materials produced in this thesis are
proof-of-concept for the development of future biomaterials for cell and drug delivery.
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Chapter 1

1

Introduction

1.1 Dendrimers: Structure, Synthesis, and Properties
Since the 1980s, dendrimers have garnered much interest due to their structural precision
and functional diversity.1 Dendrimers are a special group of molecules known for their
compact tree- like structures and large number of peripheral groups.2 A dendrimer is
comprised of three components: (i) a central core (ii) interior branches (generations) and
(iii) peripheral functional groups (Figure 1.1).3 Diverse combinations of these components
and structural precision make dendrimers of interest for various applications.4 Identical
fragments called dendrons grow from or are attached to the central core to produce the
globular dendritic macromolecule.4

Figure 1.1. a) Dendron, b) Dendrimer.
Dendrimers are synthesized by either divergent or convergent syntheses (Figure 1.2).4-5 In
divergent synthesis, the core molecule reacts with dendron repeating units called
monomers to produce a first-generation dendrimer.4-5 Then, after the activation of
peripheral groups on the dendrimer, they are reacted with monomers to afford the secondgeneration dendrimer.4-5 This process is repeated to grow the dendrimer layer-by-layer. In
contrast, convergent synthesis begins from the periphery and moves inwards towards the
core.

4-5

Dendrimers with high generations are often prepared more easily by divergent

synthesis due to the sterics introduced by the convergent method.1
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Figure 1.2. Divergent and convergent synthesis of dendrimers.
The type and number of peripheral groups strongly influence the solubility,
biocompatibility, and reactivity of dendrimers.4, 6 Introducing hydrophilic or hydrophobic
functional groups at the termini or along the dendritic backbone can diversify the
macromolecule’s applications. 4 Najafi and coworkers synthesized an amphiphilic Janus
dendrimer containing triazole branching points and a polar and non-polar wedge comprised
of terminal hydroxyl and benzyl phenyl ether moieties, respectively (Figure 1.3).7 The
dendrimers self-assembled into vesicles in aqueous solution where manipulation of spacer
length and dendrimer generation influenced the assembly shape.7 The versatile Janus
dendrimer affords potential applications in drug delivery and catalysis.7

Figure 1.3. Amphiphilic Janus dendrimer reported by Najafi and coworkers. Red and blue
correspond to non-polar and polar moieties, respectively.7
Dendrimers with particular terminal functional groups, such as primary amines, are found
to exhibit toxic effects to various cell types, while hydroxyl and carboxyl groups
demonstrate reduced cytoxicity.6 At low pH, amine terminated polyamidoamine
(PAMAM) dendrimers become cationic and demonstrate toxicity in the body.8 Toxic

3

effects on red blood cell membrane proteins tends to increase with higher generations, more
peripheral groups, and large concentrations of dendrimer.8 In contrast, carboxylic acid
terminated PAMAM dendrimers did not exhibit cell toxicity over a broad concentration
range.8

1.2

Self-immolative Dendrons (SIDs)

1.2.1

Structure and Properties

A dendron that disassembles into small molecule components upon a cleavage event at the
core is known as a self-immolative dendron (SID) (Figure 1.4).9 Notably, this amplified
response from a single cleavage event makes SIDs desirable for biological applications,
among other fields, as they are sensitive to low stimulus concentrations.8 Furthermore, the
structural precision of dendrimers allows for predictable disassembly behaviour. De Groot
et al. and Amir et al. were the first to introduce self-immolative systems that produced an
amplified response when exposed to an external trigger.3, 9 For the past decade, researchers
have developed various scaffold designs that employ unique stimuli-responsive cores,
disassembly systems, and tail units.

Figure 1.4. A core is cleaved off in response to an external stimulus; b) Removal of the
core results in the disassembly of the SID; c) The fragmentation products include the core
and derivatives of the interior and terminal groups.
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1.2.2

SID Fragmentation Methods

Specific chemical functionalities must be incorporated into the SID to achieve a cascade
mechanism that results in the release of molecules at the periphery.2 These functionalities
are incorporated into the structure of the core, interior branches (spacers), and periphery of
the dendrimer. The spacer is an important component of SIDs as it relays a cleavage event
from one end of the spacer to the other. Spacers rely on an electronic cascade or
intramolecular cyclization for disassembly.9 Among other functionalities, SIDs containing
an aromatic moiety with a hydroxyl, amino, or thiol substituent in the ortho or para location
undergo electronic cascade disassembly.9 Upon activation, degradation occurs by either
1,4-, 1,6-, or 1,8-elimination reactions (Figure 1.5).9 Intramolecular cyclization involves a
nucleophilic attack on an electrophilic aliphatic carbon or carbonyl carbon.9 The N,N′dimethylethylenediamine cyclization spacer is commonly used in SIDs and its cyclization
has proven to be the rate-limiting step in various SID fragmentation mechanisms.6
Furthermore, increasing the spacer length has been shown to reduce steric hindrance along
the SID scaffold.6 Electronic cascade and intramolecular cyclization can both be employed
for SID fragmentation. Researchers have investigated various backbones that degrade
using the methods mentioned above. Commonly used backbones include benzyl
carbamates/carbonates, benzyl ethers, and cinnamyl carbamates/carbonates.8-11

5

Figure 1.5. SID fragmentation by a) 1,4-elimination, b) 1,6-elimination, c) 1,8-elimination,
d) 1,5- cyclization.

1.2.3

Poly(ethylene glycol) (PEG)

PEG is an FDA approved linear hydrophilic polymer (Figure 1.6).12 PEG can by
synthesized by the anionic polymerization of ethylene oxide and hydroxyl initiators.13 The
polymer is commercially available in various molecular weights and architectures, such as
branched, star, and comb geometries.13 Properties of PEG vary depending on the molar
mass of the polymer where between 200-700 g/mol PEGs are liquids, 700-2000 g/mol
PEGs are semi-solid, and > 2000 g/mol PEGs are crystalline solids.14 PEG’s solubility in
water and organic solvents, as well as its low toxicity and compatibility with the human
immune system makes it ideal for drug delivery applications.12, 14 Additionally, PEG is
often coupled with substrates to improve the substrate’s hydrophilicity and prevent
aggregation in aqueous solution.12 The Gillies group developed amphiphilic block
copolymers by capping the ends of poly(ethyl glyoxylate) (PEtG) with PEG chains.15 The
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copolymer self-assembled into nanoparticles in aqueous solution and could be triggered by
external stimuli to release drug molecules.15

Figure 1.6. Chemical structure of PEG.

1.2.4

Photosensitive SIDs

Photosensitive SIDs fragment into various molecular fragments upon exposure to a light
stimulus.16 Light activation is attractive due to its simple application and tunable
parameters like wavelength, intensity, and exposure time.16 Notably, irradiation allows for
a predictable fragmentation event as the trigger typically only effects the targeted portion
of the SID.16 UV and near-infrared (NIR) are commonly used light stimuli, but NIR is often
favoured for biological applications since the former is more damaging to tissues.16 SIDs
that undergo photocleavage from UV or NIR irradiation have either o-nitrobenzyl or 4bromo-7-hydroxycoumarin (Bhc) moieties (Figure 1.7).16 Upon light exposure, the SID
disassembles into small molecules in a domino-like fashion.16

Figure 1.7. a) o-Nitrobenzyl, b) 4-Bromo-7-hydroxycoumarin photosensitive moieties
(red).
Bochet and Kastrati synthesized a first-, second-, and third-generation SIDs composed of
a o-nitrobenzyl unit at the focal point, benzyl ether spacers, and nitrophenol moieties at the
peripheries (Figure 1.8).17 A single trigger event by UV irradiation led to an electron
cascade disassembly by 1,4-elimination.17 The authors reported a third-generation SID that
releases the highest number of peripheral groups to date. The first-, second-, and third-
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generation SIDs released three, nine, and twenty-seven nitrophenol moieties,
respectively.17 Release of p-nitrophenol reporter molecules was monitored by Ultravioletvisible (UV-vis) spectroscopy.17

Figure 1.8. Photosensitive a) First-, b) Second-generation SIDs reported by Brochet and
Kastrati, R corresponds to p-nitrophenoxy moieties.17

1.2.5

Chemically-responsive SIDs

SID fragmentation initiated by chemical species, such as proteins and bioactive molecules,
allow for more versatile in vitro and in vivo applications.18 Chemical activation is appealing
due to the numerous chemical triggers that are compatible with biological systems.18
Increased hydrophobicity at higher generations can cause the SID to form aggregates in
aqueous solution, thereby hindering the chemical trigger’s ability to access the core and
disassemble the dendritic network.19 However, second-generation SIDs with polar
attributes have been successfully disassembled by chemical activation.
Shabat and coworkers were the first to report a second-generation SID that released four
anticancer drug molecules upon a single enzymatic trigger event by penicillin-G-amidase
(PGA) (Figure 1.9).20 The authors prevented aggregation of the scaffold and increased its
hydrophilicity by conjugating poly(ethylene glycol) (PEG) chains to the periphery of the
SID.20 This modification ensured the enzyme could access the dendritic activation site.
Activation triggered a series of intramolecular cyclizations and quinone methide
rearrangements to release four camptothecin drug molecules.20 Release of the anticancer
agent was monitored by high performance liquid chromatography (HPLC).
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Figure 1.9. Enzymatically activated second-generation SID reported by Shabat and
coworkers.20

1.2.6
Shabat

Benzyl Carbamate/Carbonate Backbones
and

coworkers

designed

a

first-generation

SID

containing

a

N,N′-

dimethylethylenediamine cyclization spacer, a bis(hydroxymethyl)-p-cresol moiety on one
end up the spacer, a photolabile nitrobenzyl core on the other end, and pyrene reporter
molecules (Scheme 1.1).21 Upon activation, the spacer undergoes cyclization to afford a
phenol to ultimately releases the peripheral groups through a 1,4-quinone-methide
elimination.21 The single cleavage event was amplified by introducing two hydroxymethyl
substituents on the bis(hydroxymethyl)-p-cresol moiety.21 The dual substitution allows for
a double 1,4-quinone-methide elimination and increases the number of peripheral groups
compared to a single substitution.21 Kinetic studies revealed that intramolecular cyclization
is the rate-limiting step.21 Release of the pyrene reporter molecules was monitored by
HPLC.21
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Scheme 1.1. Fragmentation of a photolabile first-generation SID by 1,5-intramolecular
cyclization followed by two 1,4-quinone-methide rearrangements resulting in the release
of terminal pyrene molecules, as reported by Shabat and coworkers.21
The group also successfully synthesized a third-generation SID using a tertbutoxycarbonyl (Boc) trigger group, a N,N′-dimethylethylenediamine cyclization spacer,
and a bis(hydroxymethyl)-p-cresol amplifying unit.21 However, the pyrene reporter
molecules were exchanged for 4-nitroaniline units to circumvent steric problems associated
with higher generation SIDs (Figure 1.10).21 For activation, trifluoroacetic acid (TFA) was
used to deprotect the Boc group to form an amine.21 Upon activation, the third-generation
SID fragmented through intramolecular cyclization and a series of 1,4-quinone-methide
eliminations.21 Release of the 4-nitroaniline reporter molecules was monitored by HPLC
and UV-vis spectroscopy.21
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Figure 1.10. Third-generation SID containing a Boc core and peripheral 4-nitroaniline
moieties, as reported by Shabat and coworkers.21

1.2.7

Benzyl Ether Backbones

McGrath and coworkers reported SIDs with benzyl ether backbones in 2003.22 The authors
synthesized zeroth- to second-generation SIDs with a 4-allyloxy group at the trigger site
and p-benzyl ether linkages, leading to a p-nitrophenoxy unit (Figure 1.11).22 A pnitrophenoxy moiety was installed at the end opposite to the allyl group such that allyl
deprotection led to a fragmentation mechanism towards the release of p-nitrophenoxide.22
Allyl deprotection triggered by Pd(PPh3)4 and NaBH4 initiated SID disassembly by a 1,6elimination mechanism.22 A single cleavage event resulted in complete disassembly of the
SID within 15 minutes.22 Release of the p-nitrophenoxide reporter molecule was monitored
by UV-vis spectroscopy.22
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Figure 1.11. a) Zeroth-, b) First-, c) Second-generation SIDs containing a 4-allyloxy
trigger group, benzyl ether backbones and a terminal p-nitrophenoxy unit as reported by
McGrath and coworkers.22
The McGrath group enhanced the SID design above by developing a dendritic
amplification system.23 They designed a first- and second-generation SID containing an
allyloxy moiety at the core with benzyl ether subunits leading to numerous p-nitrophenoxy
groups at the peripheries (Figure 1.12).23 Activation by allyl deprotection induced SID
fragmentation through a 1,4-quinone-methide elimination. Disassembly of a single 2,4branched benzyl ether subunit resulted in the release of two reporter molecules.23 Complete
disassembly was observed by UV-vis spectroscopy where a decrease in absorption at 310
nm with an increase in the absorption of p-nitrophenoxide at 431 nm was monitored.23
Kinetic studies revealed that allyl deprotection is the rate-limiting step while SID
disassembly occurred rapidly.23
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Figure 1.12. Second-generation dendron containing a 4-allyloxy trigger group, benzyl
ether backbone and four terminal p-nitrophenoxy units, as reported by McGrath and
coworkers.23

1.2.8

Cinnamyl Carbamate/Carbonate Backbones

Shabat and coworkers developed a novel first-generation SID containing a cinnamyl
carbamate backbone.24 The SID consisted of a Boc trigger group, a N,N′dimethylethylenediamine cyclization spacer, and a cinnamyl moiety leading to six
aminomethylpyrene reporter units (Figure 1.13).24 Activation by Boc deprotection using
TFA induced an intramolecular cyclization followed by six quinone methide
rearrangements to release the reporter molecules.24 Using HPLC, intramolecular
cyclization of the amine was found to be the rate-limiting step.24 Release of free
aminomethylpyrene molecules was monitored by fluorescence spectroscopy.24
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Figure 1.13. First-generation SID with a cinnamyl-based backbone as reported by Shabat
and coworkers.24
DeGroot and coworkers developed a novel second-generation SID containing a cinnamylbased backbone.25 The SID contained a 4-aminobenzyl moiety at the focal point and 4aminocinnamyl spacer units leading to four paclitaxel drug molecules at the periphery
(Figure 1.14).25 A zinc acetic acid mediated reduction of the nitro group at the focal point
resulted in a 1,8-elimination along the SID towards the release of the drug molecules.25
Release of paclitaxel was monitored by thin-layer chromatography (TLC), mass
spectrometry (MS), and nuclear magnetic resonance (NMR) spectroscopy.25
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Figure 1.14. Second-generation SID with a cinnamyl-based backbone as reported by
DeGroot and coworkers.25

1.2.9

Applications of SIDs

The structural tunability and precision of SIDs allow for applications in biomaterials,
agriculture, and catalysis.26 Researchers have spent the past decade investigating the use of
SIDs in drug delivery and sensor applications.18, 27 Shabat and researchers developed a
novel trimeric SID scaffold comprising an enzymatic substrate at the core and three
different anticancer drugs at the termini (Figure 1.15).27 A single activation event at the
core induced by an enzymatic cleavage led to an intramolecular cyclization and a series of
quinone methide rearrangements with the subsequent release of drug molecules.27 Notably,
the disassembly was successful under physiological conditions and the release of drug
molecules was monitored by HPLC. Additionally, the degradation products had minimal
to no toxicity to a human cell line.27 The group has developed a promising drug delivery
system to inhibit tumor growth that can be further manipulated to advance research in
cancer therapy.
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Figure 1.15. A trimeric SID developed by Shabat and researchers.27
SID disassembly can be monitored by the release of fluorescent or UV-visible reporter
molecules.18 Additionally, SIDs can adopt a biosensor model for the detection of
contaminants, metals, and pathogens in the environment or harmful biological entities,
such as bacteria and viruses.18 Shabat and researchers have synthesized a novel SID that
dissembles through a dendritic chain reaction (DCR) under aqueous conditions.28 The DCR
fragmentation technique exponentially amplifies a diagnostic signal where the activation
of one SID by an analyte led to the release of reagent and reporter molecules.28 Through a
chemical reaction, the reagent molecules are converted to the analyte, which can then go
on to activate more SIDs.28 Shabat and coworkers synthesized a SID triggered by hydrogen
peroxide and disassembly of the SID released a 4-nitroaniline reporter and two choline
units.28 Oxidation of the choline molecules to hydrogen peroxide allowed for further
activation while fragmentation was monitored by the release of the yellow reporter
molecule.28 Overall, development of a viable signal amplification technique is attractive
for diagnostic applications where analyte sensitivity is improved through a feedback
system.

1.2.10 Rotational Isomers
Rotational isomers, or rotamers, are isomers produced by rotation about a single bond at
room temperature.29 The restricted rotation about a sigma bond affords conformational
isomers due to different spatial arrangements of atoms in the molecule.29 Rotations between
the amino and carbonyl groups about the α-carbon in peptides is frequently observed
(Figure 1.16 a).30 Similarly, restricted rotation about the C-N bond in carbamates can also
produce rotamers (Figure 1.16 b).31 Typically, 1H NMR experiments of rotamers conducted
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at or below room temperature afford complicated spectra as the different isomers produce
different signals.29 However, variable temperature NMR spectroscopy is a possible
solution to simplify the 1H NMR spectra as the high temperature accelerates the rotation,
resulting in a coalescence of the separate peaks into a single peak or series of peaks.31

Figure 1.16. Bond rotation about the a) α-carbon in peptides, b) C-N bond in carbamates.

1.3

Hydrogels

1.3.1

Background

Hydrogels are a class of hydrophilic crosslinked polymeric materials that absorb large
amounts of water (Figure 1.17).32 The hydrophilicity arises from polar moieties along the
polymer backbone while crosslinking contributes to preventing dissolution.32 While
naturally occurring hydrogels have been investigated extensively, synthetic forms are
becoming more prevalent due to their functional and mechanical tunability.32 The high
water content of these three-dimensional networks mimics the composition of soft
tissues.32 This characteristic affords them numerous applications in biomaterials, among
other fields.32

Figure 1.17. Hydrogel structure.

1.3.2

Synthesis

Polymeric hydrogels can be synthesized by either chemical or physical gelation.33-35
Chemical or permanent hydrogels are formed through covalently-crosslinked networks.33-
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35

Crosslinking occurs between hydrophilic polymer chains or hydrophobic chains that are

made hydrophilic.33-35 The covalent bonds are formed by either free radical polymerization,
addition/condensation reactions, or enzymatic crosslinking.33-35 Since the bonds are nonreversible, chemical hydrogels afford strong and stable networks. Mechanical properties of
chemical hydrogels can be tuned by modifying the crosslinking method, polymer structure,
and crosslinker type.33-35 Free radical polymerizations have been extensively used as
crosslinking reactions as they are not technically demanding and the crosslinked site can
be selectively identified.36 The polymerization method employs an initiator that forms a
radical species when exposed to heat or light.36 The radical initiating species then reacts
with an unsaturated monomer to create a propagating site and chain growth proceeds until
all or most polymerizable units are consumed (Scheme 1.2).

Scheme 1.2. Mechanism of initiation, propagation, and termination for free radical
polymerization.36
Irgacure 2959 is a type I photoinitiator frequently employed for photocrosslinkable
hydrogels.37 The photoinitiator is ideal for applications in drug delivery and tissue
engineering due to its low toxicity, crosslinking efficiency, and adequate water solubility.37
Irgacure 2959 is activated at 365 nm where a homolytic bond cleavage generates two
radical species that then initiate polymerization (Scheme 1.3).37

18

Scheme 1.3. Mechanism of the UV-light activated type I photoinitiator Irgacure 2959.37
The photoinitiator lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) (scheme 1.4)
exhibits improved crosslinking efficiency, biocompatibility, and water solubility than
Irgacure 2959.37 Additionally, LAP is preferred for biological applications as it absorbs
both in the UV-light and visible light range.37-38 Anseth and researchers developed
hydrogels from a thiol-ene reaction photointiated by LAP.38 4-arm-PEG norbornene was
photocrosslinked with PEG thiol using UV-light (wavelength: 365 nm, intensity: 10
mW/cm2) in the presence of two proteins, lysozyme and TGFβ (Figure 1.18).38 With a
concentration of 40 mM for both thiol and alkene moieties, complete gel formation only
required 0.1 mM of LAP and ~60 s of UV-light exposure.38 Furthermore, the gel
successfully encapsulated the proteins and the effects of photopolymerization on protein
bioactivity

were

investigated.38

Cell

assays

indicated

that

the

thiol-ene

photopolymerization reaction had no effect on lysozyme or TGFβ bioactivity, which may
be attributed to the rapid gelation time and low photointiator concentration.38 The Anseth
group has developed a photocrosslinkable hydrogel with promising features for future
biomaterial applications.

Scheme 1.4. Mechanism of the UV-light activated type I photoinitiator LAP.37
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Figure 1.18. Photopolymerization reaction between 4-arm-PEG norbornene and PEG thiol
using the LAP initiator to form a hydrogel containing lysozyme and TGFβ molecules in
the scaffold, as reported by Anseth and coworkers.38 Purple and red circles correspond to
lysozyme and TGFβ, respectively.
Alternatively, type II photoinitiators, such as eosin Y, are also used for biomedical
applications due to their compatibility with living organisms, but they are often less
efficient than their type I counterparts due to competing processes during photoinitiation.39
Typically, a co-initiator, such as a hydrogen donor, is needed to activate the type II
photoinitiator.39 When irradiated with UV-light, triethylamine (Et3N) can donate a radical
to eosin Y to generate two radicals that then proceed to initiate polymerization (Scheme
1.5).39

Scheme 1.5. Mechanism of the UV-light activated type II photoinitiator eosin Y.39
Click reactions are a simple type of addition reaction that occur under mild conditions and
have high selectivity and yield.36 One of the most common click reactions is the copper (I)
alkyne-azide cycloaddition (CuAAC) click reaction where a Cu(II) salt and reducing agent
are commonly used to produce the Cu(I) species (Figure 1.19).40

20

Figure 1.19. CuAAC click reaction.
Hilborn and coworkers were the first to develop hydrogels utilizing click chemistry.41 The
group prepared poly(vinyl alcohol) (PVA) chains with either alkyne or azide moieties
(Figure 1.20).41 The modified PVA chains were crosslinked by a CuAAC reaction in the
presence of copper sulfate (CuSO4), sodium ascorbate, and propargylamine or
azidoethylamine functionalized PVA to form hydrogels.41 Finally, Schiff base formation is
commonly used for hydrogel synthesis where an amine reacts with an aldehyde to form an
imine bond.33 The condensation reaction is often reversible and produces pH-sensitive
products, making the crosslinking technique ideal for pH-sensitive and self-healing
hydrogels.33

Figure 1.20. (a) Azide or (b) Alkyne modified PVAs used for CuAAC reaction for
hydrogel formation, as reported by Hilborn and coworkers.41
Physical or reversible hydrogels are formed by secondary forces, such as ionic or hydrogen
bonding, hydrophobic interactions, or by entanglement of polymer chains (Figure 1.21).3335

Since the non-covalent bonds and entanglements are reversible, physical hydrogels are

weak compared to chemical hydrogels.33 The reversible interactions degrade in response
to environmental changes, such as pH, temperature, and ionic strength or when stress is
applied.33-35 Physical hydrogels can be prepared by temperature regulated self-assembly,
low pH induced hydrogen-bonding, and oppositely charged polyelectrolytes.33 Alginate
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hydrogels can be synthesized quickly under mild conditions with the use of divalent a
cation, such as Ca2+.42 When sodium alginate is immersed in a calcium chloride solution,
the sodium ions are displaced by Ca2+ ions to create a crosslinked polymer network in the
form of a hydrogel (Figure 1.22).42 Alginate-based hydrogels are attractive for biomedical
applications due to their nontoxicity, facile gel synthesis, and resemblance to the
extracellular matrix (ECM).43

Figure 1.21. Types of physical crosslinking include a) Ionic interactions, b) Hydrogen
bonding, c) Hydrophobic interactions.
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Figure 1.22. Crosslinked alginate via ionic interactions with divalent calcium cations. Blue
squares correspond to the alginate backbone.

1.3.3

Properties

A hydrogel’s ability to absorb and retain water depends on the network’s charge density
and degree of crosslinking.33 Water moves into the pores of a hydrogel containing
hydrophilic polymers, causing the network to swell.44 The increase in hydrophilicity
affords stronger polymer-water interactions and more swelling.44 In an aqueous solution,
ionic groups of the same charge in the network repel each other, causing the pores to
expand.44 Differences in ion concentration prompt water absorption and swelling of the
gel.44 Higher crosslinking density produces a tighter hydrogel, thereby decreasing space
for water absorption.44 The hydrogel’s water content at equilibrium is calculated by
equation 1, where md is the mass of the dry hydrogel and ms is the mass of the swollen
hydrogel at equilibrum.33 Equilibrium is achieved when the weight of the swollen hydrogel
does not change.33 Hydrogels are also characterized by gel content, which is the percentage
of material incorporated into the network.33 Gel content is calculated by equation 2, where
mt is the theoretical weight of the hydrogel if all material was incorporated into the
network.33
EWC =

𝑚𝑠 −𝑚𝑑
𝑚𝑠

Gel content =

𝑥 100%
𝑚𝑑
𝑚𝑡

𝑥 100%

(1)
(2)
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Hydrogels are viscoelastic materials that exhibit both elastic and viscous properties.45 A
hydrogel’s degree of elasticity can be determined by measuring its resistance to
compression, also known as the compression modulus. Compression stress is the amount
of force applied divided by the cross-sectional area of the specimen, as shown by equation
3. As a sample experiences compressional stress, it deforms by contracting. Equation 4
describes the percent contraction (strain), which is the change in length of the sample after
compression (L−L0) divided by the sample’s original length (L0), times a hundred.
Compression strength is the stress needed to fracture the material. As stress is applied to a
sample, the strain it experiences can be measured to produce a stress-strain curve (Figure
1.23).46 The compression modulus is the slope of the curve while the height is the
compression strength.46 A steep curve reflects a stiff material with a high modulus and
compression strength.46 Toughness is the amount of energy the sample absorbs before
fracturing.46 The area under the curve of a stress-stain curve measures the toughness of a
sample.46
Stress =

𝐹𝑜𝑟𝑐𝑒
𝐶𝑟𝑜𝑠𝑠−𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎

% Contraction =

𝐿−𝐿0
𝐿0

x 100%

Figure 1.23. Compression stress-strain curve.

(3)
(4)
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Increasing the crosslinking density enhances the mechanical properties of a hydrogel.44
Higher crosslinking affords stronger and more durable hydrogels that last longer.33
However, a higher crosslinking density reduces the swelling capacity of a hydrogel.44
Additionally, a fast gel time often produces a weak hydrogel as there is not enough time to
form a strong network.33 Swelling and mechanical properties can be tuned by modifying
the hydrogel structure.

1.3.4

Stimuli-responsive Hydrogels for Biomedical Applications

Stimuli-responsive hydrogels undergo changes in their chemical, physical, and mechanical
properties when exposed to external stimuli such as pH, temperature, and light.47 These
materials are referred to as smart hydrogels and have realized numerous applications. 47
Thermoresponsive hydrogels are attractive for biomedical applications as they can swell
under physiological conditions and their administration is non-invasive.48-49 The sol-gel
transition describes the transformation from a liquid state to a gel state when a critical
temperature is reached.48 Many thermoresponsive hydrogels exist as a homogenous
solutions below the lower critical solution temperature (LCST) and gels above the LCST
(Figure 1.24).

Figure 1.24. LCST phase transition of a thermoresponsive polymer in aqueous solution.
Green and blue correspond to hydrophobic and hydrophilic moieties, respectively.
N-isopropyl acrylamide (NIPAM) polymers are often used in thermoresponsive hydrogels
since the polymer’s LCST lies close to physiological temperature. Georgieva and
coworkers developed a thermoresponsive hydrogel containing the monomer NIPAM and
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crosslinker poly(ethylene glycol) diacrylate (PEGDA) by use of the initiator 4,4-azobis(4cyanovaleric acid) (ABCA) for free radical polymerization (Figure 1.25).50 The crosslinked
network afforded a hydrogel that demonstrated reversible swelling-deswelling phase
changes over a temperature range of 10-60 ℃.50 The hydrogel was loaded with galantamine
hydrobromide and the drug’s release from the scaffold was investigated.50 The network
readily released all of the loaded drug within 4 hours at 10 ℃.50 Overall, the
thermoresponsive hydrogel exhibits potential as a transdermal drug delivery system.

Figure 1.25. Free radical polymerization of NIPAM and PEGDA initiated by ABCA to
form a thermoresponsive hydrogel, as reported by Georgieva and coworkers.50
Hydrogels containing ionic groups along the polymer backbone can respond to changes in
pH through protonation or deprotonation events.47 Ionization of pendant groups in the
network causes swelling, while deionization collapses the network.47 Peppas and
coworkers synthesized four pH-responsive nanoparticle hydrogels containing acidic
moieties for the oral delivery of the hydrophobic drug doxorubicin to the gastrointestinal
(GI) tract.51 The hydrogels were synthesized by photoinitiated free radical polymerization
where the polymer backbones were composed of methacrylic acid, a grafted PEG chain,
and one of the four hydrophobic monomers (tert-butyl methacrylate, n-butyl acrylate, nbutyl methacrylate, methyl methacrylate) (Figure 1.26).51 The hydrophobic component is
important to encapsulation and retention of the hydrophobic drug while the methacrylic
acid moiety along the polymer backbone responds to changes in external pH.51 The PEG
chains improve the scaffold’s biocompatibility, stability in solution, and interaction with
the mucus layer of the GI.51 At pH 7.9, the nanoparticle hydrogel size varied from 120 to
500 nm depending on the size of the hydrophobic moiety along the polymer backbone.51
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All hydrogels demonstrated swelling at pH 4.9, thus the scaffolds are viable drug delivery
systems that can retain drug molecules in the acidic stomach and release them at the GI
tract.51

Figure 1.26. Chemical structure of pH-responsive polymers ionized under acid conditions
to afford swollen hydrogels, as reported by Peppas and coworkers.51
Like for SIDs, adjustable wavelength, light intensity, and irradiation time offer control over
light-sensitive hydrogels.52 Light irradiation can adjust the hydrogel’s swelling ratio by
modifying the scaffold’s crosslinking density and hydrophilicity.52 Further, the ability to
manipulate hydrogel properties remotely without physical contact afford light-sensitive
gels for numerous applications as biomaterials.52 Implantable hydrogels can undergo
physiochemcial changes when exposed to UV or NIR light at the implantation site.52
Exposure to UV-light can induce trans-cis isomerization where one isomer is converted to
the other.52 Typically, photoisomerization changes the length of polymer chains, thereby
causing the hydrogel to swell or shrink.52 For example, photoisomerization of azobenzene
moieties in polymer chains has been shown to alter the hydrogel’s swelling ratio where the
cis isomer enhanced swelling (Figure 1.27).52 Alternatively, photoinduced cleavage of
several crosslinking points or bonds in the polymer backbone also manipulates hydrogel
swelling.52 Cleavage of all crosslinking points in the hydrogel by light irradiation can
afford a liquid solution. Thus, a hydrogel’s sol-gel transition can be manipulated by light
irradiation.52 Sol-gel transitions can also be achieved by the incorporation of reversible
covalent bonds, such as disulfide bridges, into the network.52
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Figure 1.27. Photoisomerization of azobenzene.
Gupta and coworkers developed a photoresponsive hydrogel containing a modified
azobenzene linker that was non-covalently crosslinked to dextran, a polysaccharide.53 The
effect of UV-light exposure at 365 nm on the release of aspirin from the hydrogel was
investigated.53 The group found drug release was controlled by photoisomerization of the
azobenzene group in the scaffold’s crosslinker.53 UV-light irradiation disrupted the
hydrophobic interactions between azobenzene side chains, leading to disassembly of the
network followed by the release of encapsulated drug molecules (Figure 1.28).53 While the
azobenzene moiety did isomerize back to the trans form in the dark, the transition was too
slow to afford significant drug release.53 Overall, the group regulated the release of a
hydrophobic drug from pores of the hydrogel by photoisomerization of the azobenzene
moiety.

Figure 1.28. Photoisomerization of the azobenzene moiety in the hydrogel leading to the
release of hydrophobic drug molecules, as reported by Gupta and coworkers.53 Blue lines
and purple markers correspond to dextran and aspirin drug molecules, respectively.
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Similar to SIDs, photolabile o-nitrobenzyl moieties are employed in photoresponsive
hydrogels.52 Anseth and coworkers incorporated o-nitrobenzyl ether moieties into a PEGbased polymer functionalized with terminal acrylate groups (Figure 1.29).54 The
macromonomer was crosslinked with monoacrylated PEG by redox-initiated free radical
polymerization to afford a photodegradable hydrogel.54 Exposure to UV light decreased
the network’s crosslinking density and physical durability.54 Further, hydrogels loaded
with human stem cells demonstrated cell viability and migration in response to UV
irradiation.54 However, unlike the photolabile azobenzene, UV irradiation of the onitrobenzyl moiety is irreversible and these photoresponsive hydrogels may not accurately
reproduce the dynamic environment of the ECM. Nonetheless, the work by Anseth and
coworkers presents a framework for photolabile hydrogels as biomaterials for drug delivery
and tissue engineering.

Figure 1.29. Photolabile macromonomer containing PEG, o-nitrobenzyl moieties, and
terminal acrylate groups which crosslink with monoacrylated PEG to form a hydrogel for
tissue regeneration, as reported by Anseth and researchers.54

1.3.5

Dendritic Hydrogels for Biomedical Applications

Hydrogels containing dendritic macromolecules exhibit specific properties due to the
structural precision and branched architecture of dendrimers.34 Dendrimers can crosslink
with each other or with other polymer chains to form a hydrogel network.34 Multiple
crosslinking points can be introduced by modifications to dendrimer size, peripheral
groups, and shape.34 The structural precision of the dendrimers aids in understanding the
network’s properties and applications.34 For instance, mechanisms underlying the
scaffold’s drug loading and release are better understood when the network’s structure is
well defined.34
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Dendritic hydrogels are synthesized by either physical or chemical gelation.34 Similar to
other hydrogels, dendritic hydrogels synthesized by chemical gelation tend to be stronger
and more stable than those formed by physical gelation.34 Properties of dendritic hydrogels,
such as the degree of swelling, crosslinking density, and mechanical strength can be tuned
by structural modifications to the dendrimer.34 Numerous crosslinking points can be
introduced by tuning the number and functionality of surface groups on the dendrimer.34
As a result, dendrimer-based hydrogels can produce scaffolds with higher crosslinking
densities, enhanced mechanical properties, and reduced swelling.34 Furthermore, dendritic
hydrogels containing hydrophobic building blocks are attractive for the encapsulation and
retention of hydrophobic drug molecules.
Wang and coworkers combined the versatility of dendrimers and biocompatibility of PEGbased polymers to produce a novel poly(amido amine) (PAMAM) dendritic hydrogel as a
mimic for the ECM.55 The group developed a multifunctional fourth-generation (G4.0)
PAMAM dendrimer through PEGylation and alkene and amino acid functionalization of
peripheral amine groups (Figure 1.30 a).55 The introduction of PEG improved the
dendrimer’s biocompatibility while the conjugation of the peptide (RGDyC) triggered
proliferation of osteoblast cells.55 The terminal alkene moieties underwent photoinitiated
crosslinking with a copolymer of PEG and poly(lactic acid) (PLA) to form a dendritic
hydrogel (Figure 1.30 b).55 The dendrimer’s multiple crosslinking points improved the
gel’s mechanical properties and degree of swelling while the PEG and peptide moieties
enhanced the scaffold’s biocompatibility and cell proliferation when compared to a control
with no dendritic component.55 Overall, the researchers developed a dendritic hydrogel that
could be functionalized to tune its mechanical properties while still mimicking the ECM
and promoting cell growth.
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Figure 1.30. a) Functionalized G4.0 PAMAM dendrimer, b) Copolymer of PEG and PLA
containing peripheral acrylate groups, as reported by Wang and coworkers.55
The highly branched structure and functionality of PAMAM dendrimers was further
exploited by Yang and coworkers for ocular drug delivery.56 To ensure successful
crosslinking, acrylate groups were first conjugated to the termini of PEG chains rather than
the amine moieties around a third-generation (G3.0) PAMAM dendrimer to avoid shielding
effects by polymer chains. Thus, PEG was first reacted with acryloyl chloride, followed by
4-nitrophenyl chloroformate to afford a functionalized PEG (Figure 1.31).56 Using the
eosin Y photoinitiator, UV-light triggered crosslinking between terminal acrylate groups
afforded a viscous gel-like solution ideal for ocular drug delivery.56 The PEG moieties
provided good biocompatibility and water solubility while the hydrophobic network of the
PAMAM dendrimer aided in the encapsulation of hydrophobic antiglaucoma drugs such
as brimonidine.56 The dendritic hydrogel demonstrated a sustained release of the drug when
compared to traditional eye drop treatments, thereby requiring less doses administered and
better efficacy.56
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Figure 1.31. Synthesis route of the modified G3.0 PAMAM dendrimer functionalized with
PEG and acrylate moieties, as reported by Yang and coworkers.56

1.4

Motivation for Thesis

Researchers have extensively investigated the use of dendrimers, SIDs, and hydrogels as
biomaterials for applications in tissue engineering and drug delivery. Hydrogels containing
dendritic macromolecules exhibit specific properties due to the structural precision and
branched architecture of dendrimers.34 Furthermore, the dendrimer structure has been
exploited to tune the scaffold’s degree of swelling, crosslinking density, and mechanical
strength. While conventional dendrimer-based systems require multiple cleavage events to
release molecules from the network’s termini, self-immolative dendrimers (SIDs) release
all terminal molecules in a domino-like fashion in response to a single trigger event at the
dendron’s core.8-9 However, hydrogels synthesized using SIDs as a component of the
hydrogel network have yet to be reported. Here, we propose the synthesis of a
photosensitive SID hydrogel comprised of a first-generation or second-generation SID and
4-arm PEG. The hypothesis for this project is that the photosensitive SID hydrogels,
synthesized by a CuAAc click reaction, will afford scaffolds with enhanced mechanical
properties, fragment through a well-documented disassembly mechanism, and demonstrate
the regulated release of hydrophobic drugs when irradiated.
Chapter 2 describes the synthesis, characterization, and fragmentation of the photolabile
SID hydrogels. The mechanical durability was also investigated by measuring the
compression moduli of SID hydrogels with and without UV-light exposure. Finally, the
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nonsteroidal anti-inflammatory drug celecoxib (CXB) was incorporated into the hydrogels
and its release was examined in the presence and absence of UV-light irradiation. Chapter
3 summarizes the results obtained from chapter 2 and proposes future work for this project.
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Chapter 2

2

Development of SID Hydrogels as Drug Delivery
Systems

2.1 Introduction
Hydrogels have been of significant interest for numerous applications in the field of
biomaterials.1 Polymers such as poly(ethylene glycol) (PEG), poly(lactic acid) (PLA), and
poly(glycolic acid) (PGA) are used in biomaterials due to their low toxicity and
compatibility with the human immune system.8 These polymers can be functionalized to
include stimuli-responsive moieties and form smart hydrogels.9 Stimuli-responsive, or
smart, hydrogels undergo changes in their chemical, physical, and mechanical properties
when exposed to triggers, such as changes in pH, temperature, and irradiation with light.10
Upon stimulus exposure, they undergo chemical and physical modifications, such as
swelling changes, protonation or deprotonation events, and phase changes.11-12 While
traditional drug administration methods, such as intravenous and oral delivery typically
require multiple doses, smart gels can provide controlled drug release to specific locations
in the body.14
Hydrogels containing dendritic macromolecules exhibit specific properties due to the
structural precision and branched architecture of dendrimers.15 Dendrimers can crosslink
with each other or with other polymer chains to form a hydrogel network.15 Multiple
crosslinking points can be introduced by modifications to dendrimer size, peripheral
groups, and shape.15 Furthermore, dendrimer structure has been exploited to tune the
scaffold’s degree of swelling, crosslinking density, and mechanical strength.15 Notably, the
structural precision of dendrimers aids in understanding the network’s drug loading and
release behaviour.15 While conventional dendritic-based drug delivery systems require
multiple cleavage events to release molecules from the network’s termini, self-immolative
dendrimers (SIDs) release all terminal molecules in a domino-like fashion in response to a
single trigger event at the network’s core.16-17 The amplified response from a single
cleavage event makes SIDs desirable for drug delivery, among other fields, as they are
sensitive to low stimulus concentrations.17
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Researchers have used hydrogels to encapsulate a H2O2 sensitive SID-enzyme pair where
oxidation of enzyme derivatives generates more H2O2, resulting in disassembly of the
hydrogel by a dendritic chain reaction.18 However, hydrogel synthesis using SIDs has yet
to be reported and the design of these scaffolds should be carefully planned to ensure the
network itself and its degradation products are nontoxic.
Here we proposed the synthesis of a photolabile SID hydrogel composed of a firstgeneration SID (G1 SID) or second-generation SID (G2 SID) and 4-arm poly(ethylene
glycol) (PEG). Hydrogel synthesis was achieved by a copper catalyzed azide alkyne
(CuAAc) click reaction between the SID and PEG. The SID hydrogel fragments through
well-documented intramolecular cyclization of the N,N′-dimethylethylenediamine spacer
and 1,4-quinone methide rearrangements of the p-cresol moiety after the o-nitrobenzyl core
is exposed to UV-light, resulting in triggered breakdown of the gel (Figure 2.1).19 The SID
hydrogels exhibit high gel content and enhanced compressive moduli compared to a control
gel not containing the SID. Collectively, this work offers a hydrogel system where the
promising aspects of SIDs and hydrogels are combined to afford a scaffold with enhanced
mechanical properties, demonstrating its potential in biomedical applications.

Figure 2.1. Schematic depiction of the UV light triggered fragmentation of a G1 SID
hydrogel. Red lines, green pentagons, and orange circles represent PEG, triazole moieties,
and interior branching units of the dendrimer, respectively.
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2.2

Results and Discussion

2.2.1

Synthesis and Characterization of G1 and G2 SIDs

To synthesize G1 SID (Scheme 2.1), the mono-Boc-protected diamine 120 was reacted with
the activated carbonate 221 in a 1:1 ratio in toluene using N,N-diisopropylethylamine
(DIPEA) and 4-dimethylaminopyridine (DMAP) as the base and catalyst, respectively, to
afford the carbamate 3. Then, the Boc group on 3 was removed using TFA/CH2Cl2 at 0 ℃
for 1 hour to afford the ammonium compound 4. The low reaction temperature for the
synthesis of 3 was important since a previous attempt at room temperature resulted in
undesired intramolecular cyclization to afford o-nitrobenzyl alcohol and 1,3-dimethyl-2imidazolidinone. Compound 4 was then reacted with the activated carbonate 522 to afford
6. The t-butyldimethylsilyl (TBDMS) protecting groups on 6 were then removed by
treatment with Amberlyst-15 in methanol for 1.5 hours to afford compound 7. The reaction
time for this deprotection was carefully controlled, as longer reaction times led to
intramolecular cyclization of the deprotected alcohols to form a bicyclic carbonate.
Compound 7 was then reacted with six equivalents (equiv.) of 4-nitrophenyl chloroformate
in CH2Cl2 in the presence of catalytic pyridine to afford compound 8. Finally, compound
8 was reacted with 4 equiv. of propargylamine in toluene using DIPEA and DMAP as the
base and catalyst respectively, to afford the G1 SID.
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Scheme 2.1. Synthesis of the G1 SID.
For the synthesis of G2 SID (Scheme 2.2), compounds 9, 10, and 11 were synthesized
using the procedures reported by Shabat and coworkers with minor modifications.23 First,
the activated carbonate 5 was reacted with mono-Boc-protected diamine 120 in the
presence of DIPEA and DMAP, then the TBDMS protecting groups were removed by
treatment with Amberlyst-15 to give 10. Activation of the resulting alcohols with 4nitrophenyl chloroformate in the presence of pyridine provided compound 11. The reaction
of 11 with 4 equiv. of propargylamine in N,N-dimethylformamide (DMF) using Et3N as
the base gave compound 12. Treatment with TFA/CH2Cl2 at 0 ℃ for 1 hour afforded the
ammonium salt 13. Similar to the synthesis of compound 4, the reaction temperature for
the synthesis of 13 was important to avoid intramolecular cyclization. Finally, compound
13 was reacted with compound 8 in DMF using Et3N as the base to afford the G2 SID. The
use of 80 equiv. of Et3N was important to push the reaction to completion as a previous
attempt using 40 equiv. gave a derivative of compound 9 where only one arm reacted with
compound 13.
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Scheme 2.2. Synthesis of the G2 SID.
The chemical structures of the novel compounds were confirmed by 1H nuclear magnetic
resonance (NMR) spectroscopy,

13

C NMR spectroscopy, Fourier-transform infrared

(FTIR) spectroscopy, and electrospray ionization-mass spectrometry (ESI-MS). The 1H
NMR spectra for the G1 SID and G2 SID (Figure 2.2) contain peaks with similar chemical
shifts, but differences in their peak integrals. Both spectra contain three distinct multiplets
from 8.15 - 7.02 ppm which correspond to protons on the aromatic rings. The broad singlets
at ~ 5.52 ppm and ~ 5.03 ppm correspond to methylene protons adjacent to the onitrobenzyl and p-cresol moieties, respectively. Multiplets from 4.01 – 2.84 ppm are
attributed to protons in the diamine linkers and methylene protons adjacent to the alkyne
groups. Finally, signals from 2.37 – 2.14 ppm correspond to methyl protons in the p-cresol
ring and terminal alkyne protons. For both dendrons, the spectra are complicated by the
presence of rotational isomers about the C-N bonds in the carbamates.
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a)

b)

Figure 2.2. 1H NMR spectra of (a) G1 SID and (b) G2 SID (400 MHz, CDCl3).
Asterisks correspond to ethyl acetate. Rotamers are observed about the carbamate bonds.

2.2.2

Degradation of G1 and G2 SIDs

To confirm that the new dendrons would degrade in a similar manner to SIDs with the
same polycarbamate backbone but different peripheral and focal point groups,23 the G1 and
G2 SIDs were dissolved in deuterated phosphate buffer saline:dimethylsulfoxide
(PBS:DMSO-d6) (1:1.25 for G1 SID and 1:3.5 for G2 SID) and degradation was triggered
by 0.5 h of UV (365 – 370 nm) light irradiation with an intensity of 10 mW/m2. The
expected

SID

degradation

products

include

o-nitrosobenzaldehyde,

N,N′-

dimethylimidazolidinone, CO2, propargylamine, and p-cresol (Scheme 2.3, Figure A1).
SID degradation was monitored using 1H NMR spectroscopy (Figures 2.3, A2), where
disappearance of the methylene protons adjacent to the p-cresol unit at ~5.52 ppm and the
appearance of singlets at 3.18 and 2.58 ppm indicated cleavage of the photolabile core,
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followed by intramolecular cyclization, 1,4-elimination, and decarboxylation reactions of
the SID. The degradation time was monitored by using DMSO as the internal standard
against which to integrate the singlet at 3.18 ppm, corresponding to the methylene protons
in the N,N′-dimethylimidazolidinone. These analyses indicated that the G1 SID and G2
SID took about 10 and 18 days, respectively, to completely degrade. The longer
degradation time of the G2 SID is attributed to the requirement for a longer sequence of
reactions for backbone fragmentation from the core to the periphery, consistent with the
results of Shabat and coworkers for SIDs.16

Scheme 2.3. Proposed degradation products of G1 SID exposed to 0.5 h of UV irradiation
in PBS:DMSO-d6 (1:1.25).
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Figure 2.3. 1H NMR degradation profile of the G1 SID in deuterated PBS:DMSO-d6
(1:1.25) (D2O, 400 MHz). *denotes an irradiation exposure of 0.5 h. Red and green
markers correspond to methylene and methyl protons, respectively, in the N,N′dimethylimidazolidinone degradation product.

2.2.3

Synthesis and Characterization of PEG Derivatives

Hydrogel synthesis requires network formation, and with the SIDs this network formation
requires reaction with a water-soluble molecule having greater than two azides. PEG is
widely used in hydrogel preparation as well as many biomedical applications.24-25
Therefore, a 2000 g/mol 4-arm-PEG was first activated with tosyl chloride groups to afford
the tosylate 14, which was then reacted with 40 equiv. of sodium azide in deionized (DI)
water to provide the 4-arm-PEG-azide (Scheme 2.4).
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Scheme 2.4. Synthesis of 4-arm-PEG-azide.
In addition, a control, non-UV-responsive bisalkyne was prepared to enable the preparation
of non-stimuli-responsive hydrogels for comparison with the SID hydrogels. Following a
procedure previously reported for TEG monomethyl ether by Opsteen and coworkers,26
TEG was functionalized with two terminal alkyne moieties by reaction with 4 equiv. of 4pentynoic acid in CH2Cl2 using N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC)
hydrochloride and DMAP as the activating agent and catalyst, respectively, to afford the
TEG-alkyne (Scheme 2.5).

Scheme 2.5. Synthesis of TEG-alkyne.
These PEG derivatives were characterized by 1H NMR, 13C NMR, and FTIR spectroscopic
methods. The 4-arm-PEG-azide was also characterized by size exclusion chromatography
(SEC) (Figure A3) where the number average molar mass (Mn), weight average molar mass
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(Mw) and dispersity (Đ) were obtained using refractive index detection and analyzed
relative to poly(methyl methacrylate) (PMMA) standards. The Mn, Mw, and Đ values
obtained were 2814 kg/mol, 2914 kg/mol, and 1.05. Since PMMA standards were used for
SEC analysis, molecular weights of the 4-arm-PEG-azide starting material were
overestimated.

2.2.4

Synthesis and Characterization of Hydrogels

The TEG-alkyne, G1 SID, and G2 SID were reacted with the 4-arm-PEG-azide by a
CuAAC click reaction to determine if gelation was possible (Scheme 2.6). The CuAAC
click reaction has been extensively employed due to its ease of implementation and high
yield.27 Although the use of a copper catalyst is not ideal for biomedical applications, the
metal can be efficiently removed using a chelating agent, or the reaction can be replaced
with a strain-promoted version quite readily in future work. The reaction was performed in
4:1 DMF:H2O to dissolve the dendrons and other reagents and a 1:1 stoichiometric ratio of
alkyne:azide functional groups was used. Three different formulations were prepared
comprising 10, 15, or 25% w/v of 4-arm-PEG-azide, along with CuSO4 and sodium
ascorbate (Table A1).

Scheme 2.6. Hydrogel formation by a click reaction between an alkyne species and 4-armPEG-azide.
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Table 1. Gel content (%) and EWC of the different hydrogel formulations.
Alkyne Hydrogel

TEG-alkyne

G1 SID

G2 SID

Polymer
Concentration
(% w/v)

Gel Content
(%)

EWC (%)

10
15
25
10
15
25
10
15
25

92 ± 11
94 ± 2
91 ± 3
88 ± 5
94 ± 5
90 ± 3
95 ± 2
95 ± 1
96 ± 1

94 ± 1
91 ± 0.3
87 ± 3
91 ± 2
88 ± 1
80 ± 5
94 ± 1
89 ± 1
80 ± 2

The hydrogels were characterized by their gel content and EWC (Table 1). Gel content is
the percentage of SID and polymer incorporated into the network while EWC measures the
gel’s water content at equilibrium.28 The gel content was high ( 88%) for all of the
formulations, with the G2 SID generally giving the highest gel content ( 95%) and lowest
sample to sample deviation. However, there were no statistically significant differences
between any of the samples. The EWC decreased as the polymer concentration increased
for each series of hydrogels, which can likely be attributed to the formation of a more
densely crosslinked network at higher concentration. In addition, the G1 and G2 SID
systems had lower EWC than the TEG-alkyne hydrogel, likely due to the dendron
component being less hydrophilic than TEG. Although not obvious from the gel content
and EWC, the hydrogels synthesized from 10% polymer were soft and susceptible to
collapse if handled (Figure A4). However, gels formed from 15 and 25% polymer were
more mechanically robust. The improved mechanical properties at higher polymer content
can be attributed to the expected higher density of crosslinks. Based on these observations,
hydrogels containing 15% polymer were chosen for further studies.

2.2.5

Copper Content in SID Hydrogels

Following the gel synthesis, the SID hydrogels were assessed for copper content by
inductively coupled plasma-mass spectrometry (ICP-MS). Copper content in biomaterials
should be limited as high concentrations of the metal can result in liver damage and
gastrointestinal complications in humans.29 The National Institute of Health determined
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that tolerable daily upper intake levels of copper for infants, adolescents, and adults is 1,
5, and 10 mg, respectively.30 Further, the average adult typically has a total body copper
content of 50-120 mg.31 The ICP-MS instrument detection and reporting limits were 1.26
and 3.78 μg/g, respectively. The concentration of copper in the G1 SID was determined to
be below the testing method’s detection limit while the G2 SID had a copper concentration
of 10.48 μg/g. The tighter network formation in the G2 SID gel can potentially explain the
scaffold’s higher copper concentration. Nonetheless, greater than 99.9% of the initial
copper was removed from the G2 SID gel.

2.2.6

Degradation of the Hydrogels

To evaluate their degradability, accurately measured quantities of the TEG and SID
hydrogels were immersed in deuterated PBS containing 1% acetonitrile as an internal
standard. Initially, only peaks corresponding to HOD and acetonitrile were observed by
1

H NMR spectroscopy, as the remaining molecules were tied up in the polymer network

(Figures 2.4, A5). At defined time points, the hydrogels were then irradiated for 0.5 h with
UV light to trigger the fragmentation of the dendrimer backbone, while control hydrogels
were stored in the dark. Over time, peaks emerged at 3.72, 3.38, and 2.75 ppm. The peak
at 3.72 ppm is attributed to solubilized PEG while the two singlets further upfield
correspond to methylene protons in the N,N′-dimethylimidazolidinone formed by
intramolecular cyclization of the N,N’-dimethylethylene diamine spacer. The percent
degradation over time was quantified based on the integration of the PEG peak compared
to the acetonitrile standard peak at 2.1 ppm. The G1 SID hydrogel degraded more than
40% over 1 day after the first irradiation, compared to the G2 SID hydrogel which degraded
18% over the same time frame (Figure 2.5). The slower degradation of the G2 SID
hydrogel, compared to the G1 SID hydrogel, can likely be attributed to its more densely
crosslinked network, due to it having four reactive alkynes compared to two. In addition,
as described above, the G2 SID requires longer to degrade, due to a larger number of
sequential reactions required to degrade the backbone from core to periphery. Subsequent
irradiations resulted in increased hydrogel degradation, indicating that the initial irradiation
did not cleave all of the o-nitrobenzyl moieties. This feature could be of interest as the
hydrogel can be degraded in a controlled manner on demand through multiple irradiations.
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In contrast to the irradiated hydrogels, 1H NMR signals attributed to the degradation
products did not appear in the spectra of the non-irradiated SID hydrogels, demonstrating
their stability in PBS in the absence of triggering.

a)

b)

Figure 2.4. 1H NMR spectra of (a) non-irradiated, (b) irradiated G1 SID hydrogel in
deuterated PBS:acetonitrile (100:1) (D2O, 400 MHz). *denotes an irradiation exposure of
0.5 h followed by 1 h incubation at 37 ℃. Red and green markers correspond to
methylene and methyl protons, respectively, in the N,N’- dimethylimidazolidinone
degradation product.
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Figure 2.5. Degradation (%) of G1 and G2 SID hydrogels over time in deuterated PBS:
acetonitrile (100:1). Arrows denote an irradiation exposure of 0.5 h followed by incubation
at 37 ℃ for1 h before measurement at the subsequent time point.
While the

1

H NMR spectra of the TEG-alkyne hydrogels did not show peaks

corresponding to the N,N′-dimethylimidazolidinone degradation product, the PEG peak
appeared within 7 days for both the non-irradiated and irradiated hydrogels (Figures A6,
A7) and can be attributed to the hydrolysis of the ester linkages in the network, whereas
the SID hydrogels did not have ester linkages. Thus, although it was a useful comparison
for examining the gel content and EWC, the TEG-alkyne hydrogel is not highly stable in
the PBS.

2.2.7

Compression Moduli of TEG-alkyne and SID Hydrogels

The compressive moduli of the hydrogels were measured in PBS at 37 C under unconfined
compression. The G1 and G2 hydrogels were incubated for six days in PBS either with or
without irradiation. Without irradiation, the G2 SID had a significantly higher modulus of
144  10 kPa compared to 93  3 kPa for the G1 SID hydrogel, which can be attributed to
its more densely crosslinked network (Figure 2.6). After irradiation with UV light, the
modulus of the G1 SID hydrogel decreased more than 2-fold to 42  7 kPa. This decrease
can be attributed to substantial degradation of the hydrogel network, as supported by the
1

H NMR spectroscopy results described above. After irradiation, the modulus of the G2

SID hydrogel was 123  20 kPa, which was not significantly different statistically from
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that of the non-irradiated G2 SID hydrogel. The more densely crosslinked network and
slow G2 dendron degradation likely contribute to retention of mechanical properties for
the G2 SID hydrogel. Harsher irradiation conditions, such as longer and more frequent UV
exposure events would be required to observe significant differences in compression
moduli.
As noted based on the 1H NMR spectroscopy studies of hydrogel degradation, the TEGalkyne hydrogels were not sufficiently stable to be incubated in PBS for 6 days. However,
TEG-alkyne based hydrogels incubated for 1 day either with or without UV irradiation
showed no significant difference in compressive moduli. Thus, in agreement with 1H NMR
data (Figures A6, A7), UV exposure did not initiate or accelerate hydrolysis of the TEGbased scaffold. It was also noted that the non-irradiated SID hydrogels had significantly
higher moduli than the TEG-alkyne hydrogel, which suggests that the incorporation of a
more hydrophobic crosslinker into the network led to enhanced mechanical properties.

Figure 2.6. Compressive moduli (n = 3) of non-irradiated and irradiated TEG-alkyne, G1
SID, and G2 SID hydrogels in PBS. TEG-alkyne hydrogels were irradiated for 0.5 h and
incubated at 37 ℃ for 1 day while SID gels were exposed to UV light for four hours for
four days and incubated overnight following each irradiation event. Non-irradiated
hydrogels were incubated for the same time as irradiated systems of the same formulation.
*denotes a statistically significant difference between hydrogel systems. Data was
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analyzed by a two-way ANOVA with a Tukey’s post-hoc test comparison of the means (p
< 0.05).

2.2.8

Drug Release

Having demonstrated the ability to trigger degradation of the SID hydrogels in response to
UV light, the next step was to determine whether the release of drugs from the hydrogels
could potentially be triggered. Celecoxib (CXB) (Figure 2.7) was loaded during the
hydrogels during formation through the addition of 10% w/w of CXB relative to polymer.
The average loading capacity of celecoxib (CXB) in TEG-alkyne, G1 SID, and G2 SID
hydrogel

systems

was

assessed

after

washing

the

hydrogels

with

an

ethylenediaminetetraacetic acid (EDTA) solution, followed by dionized water, and then
eluting the loaded drug from the hydrogels using CH2Cl2 and quantifying it by UV-visible
spectroscopy (Table 2). The TEG-alkyne hydrogel had the highest average CXB loading
at 7.50 ± 0.03% w/w relative to polymer, which can likely be attributed to the hydrogel’s
higher EWC and therefore increased space in the network to store CXB. The G2 SID
hydrogel had a higher CXB content (5.40 ± 0.39%) than the G1 SID hydrogel (3.45 ±
0.24). It is possible that the larger hydrophobic G2 SID domains in the hydrogel facilitate
the loading of CXB.

Figure 2.7. Structure of CXB.
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Table 2. Average loading of CXB (%) in hydrogel systems prepared from 15% (w/w) of
4-arm-PEG-azide and TEG or SID alkynes.
Alkyne
hydrogel

CXB loading (% w/w
relative to polymer)

CXB loading
efficiency (%)

TEG-alkyne
G1 SID
G2 SID

7.50 ± 0.03
3.45 ± 0.24
5.40 ± 0.39

81.9 ± 0.60
35.9 ± 0.41
61.9 ± 0.67

Release of CXB from the control TEG-alkyne hydrogel was first investigated, using UVvisible spectroscopy to quantify the released drug into 0.1 M PBS solution containing 2%
(w/w) of polysorbate 80 to solubilize the CXB. Greater than 90% of the CXB was released
over about 10 days (Figure 2.7). As an additional control, free CXB dissolution into the
release medium was also investigated, with about 6 days required to completely dissolve
the same quantity of CXB as was loaded into the hydrogel. Due to the poor solubility of
CXB, its release can be limited by its slow dissolution so this control was important to
confirm that the hydrogel rather than solubility was controlling the CXB release. In the
case of the SID hydrogels, it was necessary to use HPLC to quantify the released CXB due
to the simultaneous generation of dendrimer degradation products whose absorption
spectra would overlap with that of CXB in the UV-visible spectroscopy. Initial HPLC
studies of the G1 SID gels loaded with CXB indicated the presence of a small amount of
unconjugated G1 SID in the hydrogels. Furthermore, the retention time of free G1 SID
and CXB on HPLC were quite similar and separation proved difficult. Thus, CXB release
studies were only conducted for the G2 SID gel systems. Drug release over time from the
G2 SID hydrogel suggested release of CXB from the irradiated and non-irradiated G2 SID
hydrogels was similar to the dissolution of the free drug. As supported by the 1H NMR
spectroscopy study of dendrimer and hydrogel degradation, slow degradation of the G2
SID and G2 SID hydrogel when compared to the smaller G1 SID scaffold, could explain
the slow release of CXB from the G2 SID gel even upon UV light irradiation. Combined
with the slow CXB dissolution, it was not possible to demonstrate triggered release of CXB
from the SID hydrogels.
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Figure 2.8. Release of CXB from the TEG-alkyne hydrogel, as well as irradiated and
non-irradiated G2 SID hydrogels in PBS containing 2 wt % polysorbate80. The
dissolution rate of free CXB is included for comparison.

2.3

Conclusion

We have presented the synthesis of two novel photosensitive SID hydrogel systems and
investigated their potential as biomaterials for drug delivery. G1 and G2 SIDs were
successfully synthesized. In addition, a control non-UV-responsive bisalkyne was prepared
to develop non-stimuli responsive hydrogels for comparison to SID gels. 1H NMR
spectroscopy demonstrated that degradation of the irradiated G2 SID gel was slower than
the G1 SID gel due to the tightly crosslinked network of the former as well as the longer
time required for fragmentation of the G2 SID backbone. Further, 1H NMR spectroscopy
indicated that the TEG-alkyne hydrogel underwent hydrolysis of the ester linkages over
time in PBS solution.
Although there were no statistically significant differences between samples, the G2 SID
hydrogels tended to give the highest and most reproducible gel content values ( 95%).
Furthermore, the EWC decreased as the polymer concentration increased for each hydrogel
system, potentially due to the formation of a denser network at higher concentration. While
gels developed from 10% polymer were fragile and susceptible to collapse if handled,
scaffolds synthesized from 15 and 25% polymer were stronger due to increased
crosslinking density at higher polymer concentration. Similarly, compression testing
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indicated that the non-irradiated G2 SID hydrogel had a significantly higher modulus than
that of the G1 SID hydrogel. While irradiation with UV light did not significantly decrease
the modulus for the G2 SID hydrogel, the modulus for the G1 SID hydrogel decreased
more than 2-fold. TEG-alkyne hydrogels incubated for 1 day either with or without UV
irradiation showed no significant differences in compressive moduli. CXB loading was
assessed in all three hydrogel systems where the TEG-alkyne and G1 SID gels provided
the highest and lowest loading amount, respectively. Release of CXB from the irradiated
and non-irradiated G2 SID gels was investigated and found to be similar to the dissolution
of the free drug, potentially due to the slow degradation of the G2 dendrimer and hydrogel.
Future work will focus on developing a stimuli-responsive dendritic-based hydrogel that
demonstrates faster drug release.

2.4

Experimental

2.4.1

General Experimental Details

General Materials. Compounds 120, compound 221, and compound 522 were synthesized as
previously reported. All reactions were carried out using flame dried glassware under an
inert atmosphere of nitrogen unless otherwise stated. Pyridine, Et3N, Na2HPO4, and TFA
were purchased from Caledon Laboratory Chemicals (Georgetown, ON, Canada). N,N′dimethylethylenediamine, 4-nitrophenyl chloroformate, and 2-nitrobenzyl alcohol were
purchased from TCI Chemicals. Bis(hydroxymethyl)-p-cresol, TEG, DMSO, sodium
azide, and DIPEA were purchased from Sigma-Aldrich. DMAP was purchased from AK
Scientific. Amberlyst-15 and 4-pentynoic acid were purchased from Alfa Aesar. 4-armPEG was purchased from JenKem Technology. EDC hydrochloride was purchased from
Advanced ChemTech. NaCl was purchased from Fisher Scientific. KH2PO4 and KCl were
purchased from EMD Millipore. All chemicals were used as received unless otherwise
noted. Under a nitrogen atmosphere, toluene was distilled over sodium, while Et3N and
CH2Cl2 were distilled over CaH2.
General Procedures. Dialysis was performed using Spectra/Por 6 dialysis tubing from
Spectrum Laboratories (Rancho Dominguez, CA, USA) with a molecular weight cutoff
(MWCO) of 3.5 kg/mol. Column chromatography was performed using silica gel
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(0.040−0.063 mm particle size, 230−430 mesh). Thin layer chromatography (TLC) was
carried out using Siliaplate silica gel F254 plates (20 cm × 20 cm, 250 μm). NMR
spectroscopy was conducted on a Bruker AvIII HD 400 MHz Spectrometer (1H 400.09
MHz, 13C 100.5 MHz). The 1H and 13C chemical shifts (δ) are reported in parts per million
(ppm) relative to tetramethylsilane and were calibrated against CHCl3 (7.26 ppm) and
CDCl3 (77 ppm) respectively. Coupling constants (J) are expressed in Hertz (Hz). FTIR
spectra were recorded using a PerkinElmer Spectrum Two FTIR spectrometer with an
attenuated total reflectance (ATR) attachment and a single reflection diamond. The SEC
instrument was equipped with a Viscotek GPC Max VE2001 solvent module. Samples
were analyzed using the Viscotek VE3580 RI detector operating at 30°C, and triple
detection Malvern 270 Dual detector. The separation technique employed two Agilent
Polypore (300 x 7.5 mm) columns connected in series and to a Polypore guard column (50
x 7.5 mm). Samples were dissolved in THF (glass distilled grade) in approximately 5
mg/mL concentration sand filtered through 0.22 µm syringe filters. Samples were injected
using a 50 µL loop (56 µL volume). The THF eluent was filtered and eluted at 1 ml/min
for a total of 30 minutes. The Mn, Mw, and Đ were determined relative to PMMA standards
with molecular weight ranges of 690 – 790,000 g/mol. High-resolution mass spectrometry
(HRMS) was conducted on a Synapt high definition mass spectrometer using electrospray
(ESI) ionization in either the positive or negative ion mode. The HPLC was equipped with
a Waters Separations Module 2695, a Photodiode Array Dector (Waters 2998) and a
Kinetex C18 5um (4.6x100 mm) column connected to a C18 guard column. The PDA
detector was used to monitor Celecoxib at 254 nm. Analyte separation was obtained using
an isocratic run method with a mobile phase of acetonitrile: 0.1M KH2PO4 pH 2.4 (48:52)
at 1 ml/min for 15 min. Samples were irradiated in a UV box (wavelength: 365-370 nm,
intensity: 10 mW cm-2).

2.4.2

Synthesis of Crosslinkers and Polymers

Synthesis of Compound 3. Compound 120 (1.85 g, 9.84 mmol, 1.0 equiv), compound 221
(3.13 g, 9.84 mmol, 1.0 equiv), DIPEA (3.43 mL, 19.68 mmol, 2 equiv) and DMAP (1.20
g, 9.84 mmol, 1.0 equiv) were combined with stirring in dry toluene (90 mL). The reaction
mixture was stirred at room temperature overnight. The solvent was removed, and the crude
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residue was dissolved in CH2Cl2 (100 mL), washed with saturated Na2CO3 (3 x 100 mL),
and dried over MgSO4. The crude product was purified via column chromatography with
a gradient from 100% hexane to 50:50 hexane/ethyl acetate as the eluent yielding 1.54 g of
a yellow oil. Yield = 43%. 1H NMR (CDCl3, 400 MHz): 𝛿 8.12 – 8.02 (m, 1H), 7.70 – 7.43
(m, 3H), 5.53 (s, 2H), 3.54 – 3.32 (m, 4H), 3.15 – 2.82 (m, 6H), 1.44 (s, 9H). 13C NMR
(CDCl3, 100 MHz): 𝛿 171.0, 163.1, 155.4, 147.4, 133.6, 132.9, 129.2, 128.6, 128.5, 126.0,
125.0, 124.8, 122.5, 122.1, 115.5, 79.6, 63.9, 63.7, 47.2, 46.9, 46.7, 46.4, 46.9, 45.5, 35.3,
35.0, 34.7, 34.4, 28.3. FTIR: 2957, 1687, 1524, 1399 cm-1. MS positive ion mode (m/z):
calcd for C17H25N3O6, 366.1660; found, 366.1655 [M]+.
Synthesis of Compound 4. Compound 3 (180 mg, 0.493 mmol, 1.0 equiv) was dissolved
with stirring in dry CH2Cl2 (0.63 mL) at 0 ℃. TFA (0.75 mL, 9.86 mmol, 20 equiv) was
added dropwise and the mixture was stirred for 1 hour. The solution was concentrated to
afford 180 mg of a yellow oil. Yield = 96 %. 1H NMR (CDCl3, 400 MHz): 𝛿 8.35 – 8.24
(m, 2H), 8.09 (d, J = 8.1 Hz, 1H), 7.71 – 7.50 (m, 3H), 5.50 (s, 2H), 3.65 (t, J = 3.7 Hz,
2H), 3.36 (bs, 2H), 3.00 (s, 3H), 2.85 (t, J = 2.9 Hz, 3H).13C NMR (CDCl3, 100 MHz): 𝛿
160.4 (q, J = 160), 158.5, 147.1, 134.3, 131.1, 130.4, 129.8, 129.3, 128.9, 125.2, 125.2,
122.5, 122.4, 114.8 (q, J = 115), 65.6, 49.3, 48.9, 47.8, 46.5, 46.4, 45.7, 45.3, 35.5, 35.0,
34.1, 34.0. MS positive ion mode (m/z): calcd for C12H17N3O4, 268.1292; found, 268.1293
[M]+.
Synthesis of Compound 6. Compound 4 (170 mg, 0.636 mmol, 1.0 equiv), compound 522
(357 mg, 0.636 mmol, 1.0 equiv), DIPEA (0.22 mL, 1.27 mmol, 2.0 equiv), and DMAP
(77.7 mg, 0.636 mmol, 1.0 equiv) were combined in dry toluene (30 mL) and stirred at room
temperature overnight. The solvent was removed, and the crude residue was dissolved in
CH2Cl2 (50 mL), washed with saturated Na2CO3 (3 x 50 mL), and dried over MgSO4. The
product was purified via column chromatography with a 75% hexane/ethyl acetate solvent
system yielding 310 mg of a yellow oil. Yield = 74 %. 1H NMR (CDCl3, 400 MHz): 𝛿 8.10
– 8.05 (m, 1H), 7.71 – 7.35 (m, 3H), 7.17 (s, 2H), 5.57 – 5.51 (m, 2H), 4.65 – 4.55 (m, 4H),
3.68 – 3.44 (m, 4H), 3.19 – 2.97 (m, 6H), 2.3– 2.31 (m, 3H), 0.91 (s, 18H), 0.05 (s, 12H).
13

C NMR (CDCl3, 100 MHz): 𝛿 155.7, 155.5, 155.3, 154.0, 153.7, 147.8, 147.5, 147.4,
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143.0, 142.8, 135.2, 133.6, 133.4, 133.2, 133.0, 132.8, 132.5, 132.3, 129.6, 129.2, 128.7,
128.6, 128.4, 127.1, 127.0, 124.8, 64.0, 63.9, 60.4, 60.2, 60.1, 47.9, 47.7, 47.4, 47.0, 47.0,
46.9, 46.3, 35.8, 35.7, 35.5, 35.3, 35.2, 35.1, 34.7, 34.6, 34.4, 25.8, 21.2, 18.3, -5.4. FTIR:
2910, 1715, 1527, 1400, 1118 cm-1. MS positive ion mode (m/z): calcd for C34H55N3O8Si2,
690.3600; found, 690.3812 [M]+.
Synthesis of Compound 7. Compound 6 (300 mg, 0.456 mmol, 1.0 equiv) and 1.53 g of
Amberlyst-15 resin were combined with stirring in methanol (5 mL). The reaction was left
to stir at room temperature for 1.5 hours. Amberlyst-15 was removed via filtration and the
filtrate was concentrated to afford 249 mg of a brown oil. Yield = 83%. 1H NMR (CDCl3,
400 MHz): 𝛿 8.10 – 8.03 (m, 1H), 7.65 – 7.41 (m, 3H), 7.23 –7.17 (m, 2H), 5.58 – 5.48
(m, 2H), 4.54 – 4.43 (m, 4H), 3.73 – 3.44 (m, 4H), 3.24 – 2.96 (m, 6H), 2.40 – 2.30 (m,
3H). 13C NMR (CDCl3, 100 MHz): 𝛿 156.2, 156.0, 155.7, 147.7, 147.5, 145.1, 144.8, 136.2,
133.6, 133.5, 133.2, 132.8, 132.3, 130.5, 130.1, 129.9, 129.2, 129.0, 128.8, 128.5, 124.8,
64.3, 64.1, 60.6, 60.4, 58.2, 50.6, 47.7, 47.3, 47.1, 46.9, 46.7, 45.9, 35.9, 35.7, 35.2, 35.0,
34.9, 34.3, 20.8. FTIR: 3400, 2939, 1691, 1527, 1399 cm-1. MS positive ion mode (m/z):
calcd for C22H27N3O8, 462.1871; found, 462.2117 [M]+.
Synthesis of Compound 8. Compound 7 (240 mg, 0.520 mmol, 1.0 equiv), 4-nitrophenyl
chloroformate (630 mg, 3.13 mmol, 6.0 equiv) and dry pyridine (380 mg, 4.80 mmol, 9.2
equiv) were combined with stirring in dry CH2Cl2 (30 mL). The reaction was stirred at room
temperature overnight. The solvent was removed, and the crude residue was dissolved in
CH2Cl2 (50 mL), washed with saturated NH4Cl (3 x 50 mL) and Na2CO3 (3 x 50 mL), and
dried over MgSO4. The product was purified by column chromatography with a 50%
hexane/ethyl acetate solvent system and then precipitated in pentane to afford 240 mg of a
white solid. Yield = 59%. 1H NMR (CDCl3, 400 MHz): 𝛿 8.29 – 8.22 (m, 4H), 8.09 – 8.00
(m, 1H), 7.63 – 7.29 (m, 9H), 5.54 – 5.48 (m, 2H), 5.27 – 5.15 (m, 4H), 3.73 – 3.46 (m,
4H), 3.24 – 2.92 (m, 6H), 2.38 (s, 3H). 13C NMR (CDCl3, 100 MHz): 𝛿 155.5, 154.2, 154.0,
152.3, 146.0, 145.4, 136.4, 133.6, 132.0, 131.7, 129.0, 128.6, 127.9, 125.3, 124.9, 121.8,
66.0, 64.1, 64.0, 47.7, 47.5, 47.1, 45.7, 46.1, 35.9, 35.6, 35.3, 34.9, 34.4, 20.8. FTIR: 2946,
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1761, 1520, 1347 cm-1. MS positive ion mode (m/z): calcd for C36H33N5O16, 792.2001;
found, 792.1949 [M]+.
Synthesis of G1 SID. Compound 8 (200 mg, 0.253 mmol, 1.0 equiv), propargylamine
(0.065 mL, 1.01 mmol, 4.0 equiv), DIPEA (0.18 mL, 1.01 mmol, 4.0 equiv), and DMAP
(30.9 mg, 0.253 mmol, 1.0 equiv) were combined with stirring in dry toluene (30 mL). The
reaction was stirred at room temperature overnight. The solvent was removed, and the
crude residue was dissolved in CH2Cl2 (50 mL), washed with saturated NH4Cl (3 x 50 mL)
and Na2CO3 (3 x 50 mL), and then dried over MgSO4 to afford 150 mg of a yellow solid.
Yield =75%. 1H NMR (CDCl3, 400 MHz): 𝛿 8.10 – 8.03 (m, 1H), 7.70 – 7.30 (m, 3H),
7.24 – 7.14 (m, 2H), 5.54 (s, 2H), 5.14 – 4.92 (m, 4H), 4.00 – 3.46 (m, 8H), 3.26 – 2.95
(m, 6H), 2.38 – 2.31 (m, 3H), 2.21 (s, 2H). 13C NMR (CDCl3, 100 MHz): 𝛿 155.7, 133.6,
131.3, 130.5, 129.3, 129.0, 128.8, 128.2, 125.3, 124.9, 79.7, 71.5, 64.2, 62.5, 46.9, 35.1,
30.7, 29.7, 20.8. FTIR: 3294, 2935, 2119, 1699, 1525, 1405 cm-1. MS negative ion mode
(m/z): calcd for C30H33N5O10, 622.2144; found, 622.1957 [M]-.
Synthesis of Compound 9. Compound 522 (1.25 g, 2.22 mmol, 1.0 equiv), compound 120
(0.63 g, 3.33 mmol, 1.5 equiv), DIPEA (0.86 g, 6.66 mmol, 3.0 equiv), and DMAP (0.27
g, 2.22 mmol, 1.0 equiv) were combined in dry toluene (60 mL). The reaction was stirred
at room temperature overnight. The solvent was removed, and the crude residue was
dissolved in CH2Cl2 (50 mL), washed with saturated NH4Cl (3 x 80 mL) and Na2CO3 (3 x
80 mL), and dried over MgSO4. The product was purified via column chromatography with
a 75% hexane/ethyl acetate solvent system to afford 1.07 g of a colourless oil. Yield = 79%.
Spectral characterization data agreed with those previously reported.4
Synthesis of Compound 10. Compound 9 (1.05 g, 1.72 mmol, 1.0 equiv) and Amberlyst-15
were combined in methanol (20 mL) and the reaction was stirred at room temperature for
1.5 hours. Amberlyst-15 was removed via filtration and the filtrate was concentrated to
afford 0.51 g of a brown oil. Yield = 78%. Spectral characterization data agreed with those
previously reported.4
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Synthesis of Compound 11. Compound 10 (800 mg, 1.73 mmol, 1.0 equiv), 4-nitrophenyl
chloroformate (2.10 g, 10.42 mmol, 6.0 equiv), and dry pyridine (1.26 g, 16.0 mmol, 9.2
equiv) were combined in dry CH2Cl2 (70 mL). The reaction was stirred at room temperature
overnight. The solvent was removed, and the crude residue was dissolved in CH2Cl2 (70
mL), washed with saturated NH4Cl (3 x 70 mL) and Na2CO3 (3 x 70 mL), and dried over
MgSO4. The product was purified by column chromatography with a gradient from 85%
hexane to 100% ethyl acetate as the eluent yielding 629 mg of a white powder. Yield =
51%. Spectral characterization data agreed with those previously reported.4
Synthesis of Compound 12. Compound 11 (500 mg, 0.702 mmol, 1.0 equiv),
propargylamine (0.18 mL, 7.81 mmol, 4.0 equiv), and Et3N (1.09 mL, 7.81 mmol, 4.0
equiv) were combined in dry DMF (30 mL). The reaction was stirred at room temperature
overnight. The crude product was dissolved in CH2Cl2 (50 mL), washed with saturated
NH4Cl (3 x 50 mL) and Na2CO3 (3 x 50 mL), and dried over MgSO4. The product was
purified by column chromatography with a 40% hexane/ethyl acetate solvent system to
afford 256 mg of a yellow powder. Yield = 79%. 1H NMR (CDCl3, 400 MHz): 𝛿 7.25 –
8.7.14 (m, 2H), 5.70 – 5.16 (m, 2H), 5.03 (s, 4H), 3.99 – 3.87 (m, 4H), 3.17 – 2.88 (m, 6H),
2.31 (s, 3H), 2.21 (s, 2H), 1.51 – 1.41 (m, 9H).

13

C NMR (CDCl3, 100 MHz): 𝛿 155.8,

154.2, 154.0, 146.8, 135.7, 131.3, 130.8, 129.2, 79.9, 79.7, 71.4, 62.6, 62.4, 62.2, 47.7,
47.2, 45.8, 46.2, 35.6, 35.3, 35.2, 34.8, 30.7, 29.9, 28.4, 20.8. FTIR: 3298, 2956, 2119,
1701 cm-1. MS positive ion mode (m/z): calcd for C27H36N4O8, 567.2425; found, 567.2403
[M + Na]+.
Synthesis of Compound 13. Compound 12 (200 mg, 0.37 mmol, 1.0 equiv) was dissolved
with stirring in dry CH2Cl2 (0.60 mL) at 0 ℃. TFA (0.75 mL, 7.34 mmol, 20 equiv) was
added dropwise and the mixture was stirred for 1 hour. The solution was concentrated to
afford 148 mg of a yellow oil. Yield = 90%. 1H NMR (CDCl3, 400 MHz): 𝛿 7.25 – 7.16
(m, 2H), 5.33 – 4.93 (m, 4H), 4.02 – 3.82 (m, 4H), 3.80 – 3.22 (m, 4H), 3.20 – 2.73 (m,
6H), 2.35 (s, 3H), 2.29 – 2.18 (m, 2H).

13C

NMR (CDCl3, 100 MHz): 𝛿 160.7 (q, J =

160.8), 156.9, 156.2, 155.1, 145.8, 136.7, 132.9, 132.2, 131.9, 129.1, 125.1, 122.5, 115.6
(q, J = 115.33 Hz), 79.2, 71.9, 71.6, 63.0, 62.8, 62.4, 45.0, 47.3, 46.2, 45.8, 35.9, 33.6,
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33.4, 33.1, 31.2, 30.8, 20.7. FTIR: 3304, 2879, 2130, 1699 cm-1. MS positive ion mode
(m/z): calcd for C22H28N4O6, 445.2082; found, 445.2034 [M]+.
Synthesis of Compound G2 SID. Compound 13 (140 mg, 0.315 mmol, 6.0 equiv),
compound 11 (41.6 mg, 0.05 mmol, 1.0 equiv), and Et3N (0.56 mL, 4 mmol, 80 equiv)
were combined in dry DMF (10 mL). The reaction was stirred at room temperature
overnight. The crude product was dissolved in CH2Cl2 (50 mL), washed with saturated
NH4Cl (3 x 50 mL) and Na2CO3 (3 x 50 mL), and dried over MgSO4. The product was
purified via column chromatography with a gradient from 15% hexane:ethyl acetate to 80%
ethyl acetate:CH2Cl2 as the eluent yielding 37 mg of a yellow powder. Yield = 54%. 1H
NMR (CDCl3, 400 MHz): 𝛿 8.11 – 7.99 (m, 1H), 7.66 – 7.42 (m, 3H), 7.24 – 7.10 (m, 6H),
5.62 – 5.45 (m, 4H), 5.10 – 4.93 (m, 10H), 3.96 – 3.79 (m, 8H), 3.67 – 3.38 (m, 12H), 3.17
– 2.89 (m, 18H), 2.36 – 2.14 (m, 13H). 13C NMR (CDCl3, 100 MHz): 𝛿 156.1, 155.8, 155.4,
153.8, 147.4, 146.2, 145.5, 135.7, 133.6, 133.0, 132.4, 131.3, 130.4, 129.6, 129.3, 128.8,
128.5, 124.8, 79.8, 71.4, 64.0, 62.4, 62.1, 47.3, 46.9, 46.7, 46.0, 35.6, 35.3, 35.1, 34.8, 34.5,
31.3, 30.7, 20.8. FTIR: 3290, 2939, 2246, 1700, 1520, 1397 cm-1. MS positive ion mode
(m/z): calcd for C68H79N11O22, 1424.5293; found, 1424.5241 [M + Na]+.
Synthesis of Compound 14. 4-arm-PEG (2.00 g, 1.00 mmol, 1.0 equiv), 4-toluenesulfonyl
chloride (1.53 g, 8.00 mmol, 8.0 equiv), Et3N (0.81 g, 8.00 mmol, 8.0 equiv), and DMAP
(0.12 g, 1 mmol, 1.0 equiv) were combined in dry CH2Cl2 (10 mL). The reaction was stirred
at room temperature for 3 days. 1M HCl (50 mL) was added and the reaction mixture was
stirred at room temperature for 2 hours. The resulting solution was extracted with CH2Cl2
(3 x 50 mL), dried over MgSO4, and then precipitated in diethyl ether to afford 1.31 g of
an oil. Yield = 50%. 1H NMR (CDCl3, 400 MHz): 𝛿 7.74 (d, J = 7.7 Hz, 8H), 7.29 (d, J =
7.7 Hz, 8H), 4.10 (t, J = 4.1 Hz, 8H), 3.65 – 3.47 (m, 172H), 2.39 (s, 12H).

13

C NMR

(CDCl3, 100 MHz): 𝛿 144.3, 132.4, 129.4, 127.5, 70.5, 70.1, 69.8, 68.8, 68.2, 21.2 cm-1.
Mn = 2814 kg/mol, Mw = 2941 kg/mol, Đ = 1.05.
Synthesis of 4-arm-PEG-azide. Compound 14 (0.50 g, 0.191 mmol, 1.0 equiv) and sodium
azide (0.50 g, 7.64 mmol, 40 equiv) were combined with stirring in deionized water (10
mL) at room temperature. The reaction mixture was heated at reflux (100 ℃) overnight.
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The resulting solution was extracted with CH2Cl2 (3 x 50 mL) and dried over MgSO4. The
crude product was purified by dialysis against deionized H2O (500 mL), changing the
solution 3 times over 24 hours, using a 3.5 kg/mol MWCO membrane. The resulting
solution was freeze-dried to afford 0.25 g of an oil. Yield = 60%. 1H NMR (CDCl3, 400
MHz): 𝛿 3.71 – 3.33 (m, 180H).

13

C NMR (CDCl3, 100 MHz): 𝛿 70.6, 70.2, 69.7, 60.3,

45.2. FTIR: 2864, 2103 cm-1.
Synthesis of TEG-alkyne. TEG (500 mg, 2.57 mmol, 1.0 equiv), 4-pentynoic acid (610 mg,
6.22 mmol, 2.4 equiv), and DMAP (83.0 mg, 0.679 mmol, 0.26 equiv) were combined in
dry CH2Cl2 (5 mL) at -20 ℃. A solution of EDC hydrochloride (960 mg, 6.18 mmol, 2.4
equiv) in CH2Cl2 (2 mL) was added dropwise and the mixture was stirred at room
temperature for 20 hours. The resulting solution was washed with 1 M NaOH (2 x 50 mL),
deionized H2O (2 x 50 mL) and NH4Cl (2 x 50 mL), and dried over MgSO4 to afford 746
mg of an oil. Yield = 82%. 1H NMR (CDCl3, 400 MHz): 𝛿 4.26 (t, J = 4.3 Hz, 4H), 3.73 –
3.68 (t, J = 3.7 Hz, 4H), 3.68 – 3.64 (m, 8 H), 2.61 – 2.55 (m, 4H), 2.54 – 2.48 (m, 4H),
1.98 (t, J = 2.0 Hz, 2H). 13C NMR (CDCl3, 100 MHz): 𝛿 82.2, 72.3, 70.3, 68.9, 68.8, 63.4,
33.0, 14.0 cm-1. FTIR: 3272, 2885, 2123, 1731 cm-1.

2.4.3

Degradation of SIDs

G1 SID (10 mg) and G2 SID (11 mg) were dissolved in a 1.25:1 or 3.5:1 solution of DMSOd6:deuterated PBS, respectively. The SIDs were then exposed to 0.5 hr of UV irradiation
(wavelength: 365-370 nm, intensity: 10 mW cm-2) and then incubated at 37 ℃. SID
degradation was monitored by 1H NMR spectroscopy using the DMSO signal as the
internal standard. SID degradation was quantified by integration of the singlet at ~ 2.6 ppm
relative to DMSO-d6.

2.4.4

Hydrogel Synthesis, Characterization, and Degradation

Synthesis of the Hydrogels. Hydrogels were prepared using 10, 15, and 25% w/v of 4-armPEG-azide in 4:1 DMF:H2O, with the specific formulations provided in Table A1. The
amount of TEG-alkyne, G1 SID, and G2 SID were determined based on maintaining a
1:1 molar ratio of azide:alkyne functional group was used in each case. First, the alkyne
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and azide were dissolved in DMF (240 L). Sodium ascorbate and CuSO4 were each
dissolved separately in 30 μL of H2O and vortexed. The sodium ascorbate solution was
then added to the DMF solution and mixed by vortexing, followed by the CuSO4 solution.
The reaction mixture was bubbled with a stream of N2 gas and vented for one hour and
then left under nitrogen overnight. The resulting gels were immersed in a 0.1 M EDTA
solution (5 mL), changing the solution 3 times over 24 hours to remove copper. The gels
were then immersed in deionized H2O (5 mL), changing the solution 3 times over 24 hours.
The gels were then lyophilized.
Measurement of Gel Content and Equilibrium Water Content (EWC). Gel content and
equilibrium water content were measured in triplicate. After gelation as described above,
the initial mass (mi) of each hydrogel was recorded and the theoretical mass (mt) of
polymers involved in crosslinking was calculated as mi x the m/v % in the formulation. The
hydrogels were then immersed in 0.1M EDTA, followed by water as described above.
After the third deionized H2O treatment, the swollen mass (ms) was recorded to determine
the EWC. The hydrogels were then lyophilized and their dry masses (md) were measured.
The gel content and EWC were calculated using equations (1) and (2), respectively.
Gel content =
EWC =

𝑚𝑠 −𝑚𝑑
𝑚𝑠

𝑚𝑑
𝑚𝑡

𝑥 100%

𝑥 100%

(1)
(2)

Measurement of Compressive Moduli under Unconfined Compression. Cylindrical
samples with diameters of ~4 mm and heights of ~6 mm for the SID gels (n=3) were
prepared in 1 mL syringes as described above and equilibrated in PBS. Gels (n = 3) were
irradiated with UV light (wavelength: 365-370 nm, intensity: 10 mW cm-2) for four hours
for four days and incubated at 37 ℃. The gels were then incubated for an additional two
days. Non-irradiated gels (n=3) were also incubated for a total of six days at 37 ℃. Before
compression, the dimensions of the swollen hydrogels were accurately measured using
calipers. The compressive moduli were then determined using a UniVert system
(CellScale, Waterloo, ON, Canada) equipped with a 0.5 N load cell. During the
measurement, the samples were immersed in a 37 ℃ PBS bath, preloaded at 0.1 N and
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compressed to a total strain of 20% at a rate of 0.6% s-1. The compression moduli were
calculated from the slope of the linear region of the stress-strain curve between 10 and 15%
strain.
Degradation of SID Hydrogels. First-generation (11.3 mg) and second-generation (12.1
mg) SID hydrogels were immersed in a 1.00 mL of deuterated PBS and 10.0 L of
acetonitrile was added as an internal standard. The immersed gels were then exposed to 0.5
h of UV irradiation (wavelength: 365-370 nm, intensity: 10 mW cm-2) at t = 0 and 7 days.
The second-generation SID gel was again irradiated at 50 days. The samples were
incubated at 37 ℃. Gel degradation was monitored by 1H NMR spectroscopy with
degradation quantified based on the percentage of solubilized PEG, based on integration
of the peak at 3.75 – 3.65 ppm corresponding to the protons on PEG, compared to the
integration of the acetonitrile internal standard peak at 2.09 ppm.

2.4.5

Trace Elemental Analysis

First-generation (50 mg) and second-generation (45 mg) SID hydrogels were prepared as
mentioned above and analyzed for the presence of copper by ICP-MS (Agilent 7700 Series)
with helium gas as the plasma. The method detection and reporting limit was 1.26 and 3.78
g/g, respectively.

2.4.6

Drug Release

Calibration Curve for Celecoxib in PBS-polysorbate 80 Solution. The calibration curve for
UV-vis was obtained from the CXB standard solutions of 1, 5, 10, 15, 20, and 25 μg /mL
in 0.1 M PBS solution containing 2% w/w of polysorbate 80. Absorbance at 260 nm for
each sample was determined using UV-visible spectroscopy with the instrument method
described above (ε = 14454 M-1cm-1). The calibration curve for RP-HPLC was obtained
from CXB standard solutions of 5, 10, 25, 75, and 100 μg /mL in the same PBS-polysorbate
80 solution mentioned above. CXB levels in the samples were obtained by diluting 10 μL
of each sample 10 times with mobile phase and then through a 0.2 μm Supor membrane
filter. The samples were injected at 100μL using the instrument method described above.

67

Calibration Curve for Celecoxib in CH2Cl2. The calibration curve was obtained from the
CXB standard solutions of 1, 5, 7.5, 10, 15, 20 μg /mL in CH2Cl2. Absorbance at 260 nm
for each sample was determined using UV-visible spectroscopy with the instrument
method described above (ε = 18497 M-1cm-1).
Preparation of CXB-loaded hydrogels and quantification of loaded drug. The hydrogels
were prepared as described above, with the addition of 10% w/w (Table A1) of CXB
relative to polymer to the DMF solution containing 4-arm-PEG-azide and either G1 SID,
G2 SID, or TEG-alkyne and then the solution was vortexed for 30 seconds. Following
hydrogel synthesis, non-loaded drug, copper, and other impurities were removed by
incubation in EDTA solution, followed by water as described above. To quantify the
loading of CXB, the hydrated gels (n = 3) were accurately weighed and then immersed in
CH2Cl2. The samples were incubated overnight at room temperature in a sealed vial to
release the loaded CXB. CXB levels in the CH2Cl2 solutions were then determined using
UV-visible spectroscopy and comparison to the calibration curve determined as described
above. The samples of hydrogel swollen in CH2Cl2 were then dried and weighed to
determine the mass of polymer. The CXB loading and loading efficiency were determined
by equations (3) and (4) respectively:
CXB loading =

𝑀𝑎𝑠𝑠 𝑜𝑓 𝐶𝑋𝐵 𝑐𝑎𝑙𝑐𝑑 𝑓𝑟𝑜𝑚 𝑈𝑉−𝑣𝑖𝑠
𝑀𝑑 𝑜𝑓 𝑔𝑒𝑙 𝑐𝑜𝑛𝑡𝑎𝑖𝑛𝑖𝑛𝑔 𝐶𝑋𝐵

Loading efficiency =

𝑥 100%

𝑀𝑎𝑠𝑠 𝑜𝑓 𝐶𝑋𝐵 𝑐𝑎𝑙𝑐𝑑 𝑓𝑟𝑜𝑚 𝑈𝑉−𝑣𝑖𝑠
4.5 𝑚𝑔

𝑥 100%

(3)

(4)

Release of Free CXB. A 12.6 x 8.0 x 0.80 cm nylon bag (Supreme Rosin) (n = 3) was cut
to form a ~ 5 cm pocket square that was then loaded with 4.5 mg of CXB and sealed with
a 2.7 inch bag clip. The drug-loaded bag was immersed in 8 mL of 0.1 M PBS solution
containing 2% w/w of polysorbate 80. A 0.5 mL aliquot of each sample was diluted 5 times
with fresh PBS-polysorbate solution and the CXB content was determined using UVvisible spectroscopy by measuring the absorbance at 260 nm using the instrument method
described above. Following each reading, the drug-loaded bag was immersed in fresh PBSpolysorbate solution and incubated overnight at 37 ℃.
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CXB Release from the Non-irradiated TEG-alkyne and G2 SID Hydrogel Systems. The
experiments were performed in triplicate. CXB-loaded hydrogels were prepared as
described above. The TEG-alkyne (46.7 ± 1.6 mg) and G2 SID hydrogels (53.8 ± 1.8
mg) were immersed in 4.8 and 5.0 mL of 0.1 M PBS solution containing 2% w/w of
polysorbate 80, respectively to maintain a constant amount of hydrogel-encapsulated CXB
(same as that used to measure the solubilization rate of free CXB) in the release medium.
At defined time points, a 0.2 mL aliquot of each sample was diluted 11 times with fresh
PBS-polysorbate solution and the CXB content was determined using UV-visible
spectroscopy by measuring the absorbance at 260 nm using the instrument method
described above. Following each time point, the gels were immersed in fresh PBSpolysorbate solution and incubated overnight at 37 ℃.
CXB Release from the Irradiated G2 SID Hydrogel System. The experiments were
performed in triplicate. CXB-loaded hydrogels were prepared as described above. 55.0 ±
1.5 mg of hydrogel was immersed in 5.0 mL of 0.1 M PBS solution containing 2% w/w of
polysorbate 80, exposed to 1 h of UV irradiation (wavelength: 365-370 nm, intensity: 10
mW cm-2), and then incubated at 37 ℃ for 1 h. CXB content in the PBS-polysorbate
mixture was determined using RP-HPLC where 100 μl of the solution was diluted 10 times
using the mobile phase and then filtered through a 0.2 μm Supor membrane filter. The
samples were injected (100 μL) using the instrument method described above. After each
time point, the hydrogels were immersed in fresh PBS-polysorbate solution, exposed to 1
h of UV irradiation (wavelength: 365-370 nm, intensity: 10 mW cm-2), and then incubated
at 37 ℃. The experiment was performed in triplicate.
Statistical Analyses. Data are reported as the mean ± standard deviation (SD), and the
statistical analyses were conducted using GraphPad Prism 6 (GraphPad Software, San
Diego, CA, USA) by one-way and two-way ANOVA with a Tukey’s post-hoc test.
Differences were considered statistically significant at p < 0.05.
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Chapter 3

3

Conclusions and Future Work

Overall, this thesis presented the synthesis of novel UV-responsive SIDs functionalized
with alkyne moieties at the termini for hydrogel synthesis and investigated their application
as drug delivery systems.
Chapter 2 presented two new photolabile SIDs, G1 SID and G2 SID, that were constructed
with a o-nitrobenzyl core, N,N′-dimethylethylenediamine spacers extending from a pcresol moiety, and alkyne peripheries. A non-photosensitive TEG-alkyne species was
developed as a control. Moreover, a 4-arm-PEG-azide was synthesized with an Mn and Đ
of approximately 2814 kg/mol and 1.05, respectively. The double bonds on the peripheries
of the SIDs and bisalkyne were photochemically crosslinked with 4-arm-PEG-azide by a
CuAAC reaction. Hydrogel properties, such as gel content, EWC, and durability were
tuned by manipulating gel synthesis techniques and formulations. However, hydrogels
containing 15 and 25% (w/v) of 4-arm-PEG-azide demonstrated greater structural
integrity than scaffolds comprised of 10% (w/v) of polymer. As a result, hydrogels
containing 15% (w/v) of 4-arm-PEG-azide were selected for compression testing while
only G2 SID and TEG-alkyne scaffolds were used in drug release studies. Compression
results demonstrated that UV-light exposure afforded a statistically significant decrease in
compression modulus for only the G1 SID hydrogel. The durability of the G2 SID scaffold
is attributed to the slow degradation of the gel and SID backbone. Similarly, drug release
studies of the irradiated G2 SID hydrogel did not demonstrate an accelerated release of
CXB from the scaffold, potentially due to the slow fragmentation of the network. However,
these SID-based hydrogels are a promising proof-of-concept for the development of other
dendritic-based hydrogels as biomaterials for drug delivery.
Possible future work includes developing a hydrogel with a shorter synthesis route or a
faster network disassembly in response to an external stimulus. Ethyl glyoxylate is a
commercially available monomer and can be used to synthesize poly(ethyl glyoxylate) in
one-step.1 Poly(glyoxylates) can be end-capped with UV-responsive groups, such as 6nitroveratryl carbonate, to provide rapid depolymerization in response to irradiation.1 By
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introducing poly(glyoxylate) moieties into SIDs synthesized in this work, perhaps quicker
fragmentation upon exposure to UV-light would result in faster drug release. Alternatively,
star polymers containing a stimuli-responsive core may provide a more facile synthetic
pathway to producing a densely crosslinked hydrogel with improved mechanical
properties. Perhaps compound 12, an intermediate in the G2 SID synthesis, could be
crosslinked to thiol moieties extending from a central core, resulting in a pH-sensitive starlike scaffold that could potentially demonstrate faster degradation. Finally, drugs more
hydrophobic than CXB may be used for drug release studies of the G2 SID gel to ensure
stronger binding to the hydrophobic domains of the scaffold and avoid premature drug
leakage. Alternatively, the G2 SID could be synthesized to include more hydrophobic
moieties along the interior branches to also ensure drug retention.
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Appendix: Supplementary Figures

A1. Degradation products of irradiated G2 SID.

A 2. 1H NMR degradation profile of the G2 SID in deuterated PBS:DMSO-d6 (1:3.5) (D2O,
400 MHz). *denotes an irradiation exposure of 0.5 h. Red and green markers correspond
to methylene and methyl protons, respectively, in the N,N′-dimethylimidazolidinone
degradation product.
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A3. SEC trace of 4-arm-PEG-azide.
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Table A1. Formulations of the TEG-alkyne, G1 SID, and G2 SID hydrogels in a
DMF:H2O (240:60 μL) solution.

A4. Representative images of G2 SID hydrogels containing a) 10, b) 15, c) 25% polymer.
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A5. 1H NMR spectra of (a) non-irradiated, (b) irradiated G2 SID hydrogel in deuterated
PBS:acetonitrile (100:1) (D2O, 400 MHz). *denotes an irradiation exposure of 0.5 h
followed by 1 h incubation at 37 ℃ prior to measurement at the subsequent time point.
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A6. (a) 1H NMR (D2O, 400 MHz), (b) degradation profile of non-irradiated TEG-alkyne
in deuterated PBS: acetonitrile (100:1) incubated at 37 ℃.
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A7. (a) 1H NMR (D2O, 400 MHz), (b) degradation profile of UV-light irradiated TEGalkyne in deuterated PBS: acetonitrile (100:1) incubated at 37 ℃. *denotes to 0.5 h of UVlight exposure.
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A8. 1H NMR spectrum of compound 3 (400 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bond are observed.

A9. 1H NMR spectrum of compound 4 (400 MHz, CDCl3). Rotational isomers about the
carbamate bond are observed.
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A10. 1H NMR spectrum of compound 6 (400 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bonds are observed.

A11. 1H NMR spectrum of compound 7 (400 MHz, CDCl3). Rotational isomers about the
carbamate bonds are observed.
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A12. 1H NMR spectrum of compound 8 (400 MHz, CDCl3). Rotational isomers about the
carbamate bonds are observed.

A13. 1H NMR spectrum of G1 SID (400 MHz, CDCl3). Rotational isomers about the
carbamate bonds are observed.
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A14. 1H NMR spectrum of compound 12 (400 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bonds are observed.
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A15. 1H NMR spectrum of compound 13 (400 MHz, CDCl3). Rotational isomers about
the carbamate bonds are observed.

A16. 1H NMR spectrum of G2 SID (400 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bonds are observed.

88

A17. 1H NMR spectrum of compound 14 (400 MHz, CDCl3).

A18. 1H NMR spectrum of 4-arm-PEG-azide (400 MHz, CDCl3).
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A19. 1H NMR spectrum of TEG-alkyne (400 MHz, CDCl3).

A20. 13C NMR spectrum of compound 3 (100 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bonds are observed.
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A21. 13C NMR spectrum of compound 4 (100 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bonds are observed.

A22. 13C NMR spectrum of compound 6 (100 MHz, CDCl3). Asterisks correspond to ethyl
acetate. Rotational isomers about the carbamate bonds are observed.
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A23. 13C NMR spectrum of compound 7 (100 MHz, CDCl3). Rotational isomers about the
carbamate bonds are observed.

A24. 13C NMR spectrum of compound 8 (100 MHz, CDCl3). Rotational isomers about the
carbamate bonds are observed.
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A25.

13

C NMR spectrum of G1 SID (100 MHz, CDCl3). Rotational isomers about the

carbamate bonds are observed.

A26. 13C NMR spectrum of compound 12 (100 MHz, CDCl3). Rotational isomers about
the carbamate bond are observed.
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A27. 13C NMR spectrum of compound 13 (100 MHz, CDCl3). Rotational isomers about
the carbamate bond are observed.

A28.

13

C NMR spectrum of G2 SID (100 MHz, CDCl3). Rotational isomers about the

carbamate bonds are observed.
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A29.

13

C NMR spectrum of compound 14 (100 MHz, CDCl3). Asterisks correspond to

diethyl ether.

A30. 13C NMR spectrum of 4-arm-PEG-azide (100 MHz, CDCl3).
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A31. 13C NMR spectrum of TEG-alkyne (100 MHz, CDCl3).

A32. FTIR of compound 3.
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A33. FTIR of compound 4.

A34. FTIR of compound 6.
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A35. FTIR of compound 7.

A36. FTIR of compound 8.
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A37. FTIR of G1 SID.

A38. FTIR of compound 12.
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A39. FTIR of compound 13.

A40. FTIR of G2 SID.
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A41. FTIR of compound 14.

A42. FTIR of 4-arm-PEG-azide.
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A43. FTIR of TEG-alkyne.
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